pmid,title,is_research,screening_reasoning
10215625,Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein.,True,Transgenic mouse model
10339466,Myeloid malignancies induced by alkylating agents in Nf1 mice.,True,Animal model of myeloid malignancies
10383727,"The Nf1 tumor suppressor regulates mouse skin wound healing, fibroblast proliferation, and collagen deposited by fibroblasts.",True,Mouse model of wound healing
10433955,Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas.,True,Molecular genetic analysis method
10567424,Interdomain interaction of merlin isoforms and its influence on intermolecular binding to NHE-RF.,True,Protein interaction analysis
10591653,Mouse tumor model for neurofibromatosis type 1.,True,Mouse tumor model
10595915,Deletions of the INK4A gene occur in malignant peripheral nerve sheath tumors but not in neurofibromas.,True,Genetic mutation analysis
10595919,Expression of p27(kip) and other cell cycle regulators in malignant peripheral nerve sheath tumors and neurofibromas: the emerging role of p27(kip) in malignant transformation of neurofibromas.,True,Cell cycle regulation study
10620616,Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo.,True,Genetic and biochemical animal model
10627474,Inhibition of juvenile myelomonocytic leukemia cell growth in vitro by farnesyltransferase inhibitors.,True,In vitro cell growth inhibition
10633134,A search for evidence of somatic mutations in the NF1 gene.,True,Somatic mutation screening
10669747,"Cloning and characterization of SCHIP-1, a novel protein interacting specifically with spliced isoforms and naturally occurring mutant NF2 proteins.",True,Protein cloning and characterization
10678181,Nf1 and Gmcsf interact in myeloid leukemogenesis.,True,Genetic interaction study
10684924,Cold shock induces the insertion of a cryptic exon in the neurofibromatosis type 1 (NF1) mRNA.,True,mRNA mutation analysis
10705390,A unique method for mutation analysis of tumor suppressor genes in colorectal carcinomas using a crypt isolation technique.,True,Mutation analysis technique
10712197,Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain.,True,Genetic mutation spectrum analysis
10712203,Functional analysis of the neurofibromatosis type 2 protein by means of disease-causing point mutations.,True,Protein functional analysis
10844550,The neurofibromatosis type 1 (Nf1) tumor suppressor is a modifier of carcinogen-induced pigmentation and papilloma formation in C57BL/6 mice.,True,Animal model of carcinogen response
10887156,Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2.,True,Conditional mouse model
10900196,Single cell Ras-GTP analysis reveals altered Ras activity in a subpopulation of neurofibroma Schwann cells but not fibroblasts.,True,Single cell Ras activity analysis
11080503,Neurofibromin GTPase-activating protein-related domains restore normal growth in Nf1-/- cells.,True,Cellular growth restoration method
11106646,Hierarchy of merlin and ezrin N- and C-terminal domain interactions in homo- and heterotypic associations and their relationship to binding of scaffolding proteins EBP50 and E3KARP.,True,Protein interaction analysis
11159187,Tumorigenic properties of neurofibromin-deficient neurofibroma Schwann cells.,True,Tumorigenic cell properties study
11316791,"The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44.",True,Protein interaction analysis
11356864,Bipartite interaction between neurofibromatosis type I protein (neurofibromin) and syndecan transmembrane heparan sulfate proteoglycans.,True,Protein interaction study
11368764,"The neurofibromatosis 2 protein product merlin selectively binds F-actin but not G-actin, and stabilizes the filaments through a lateral association.",True,Protein binding characterization
11380622,Identification of the cis-acting region in the NF2 gene promoter as a potential target for mutation and methylation-dependent silencing in schwannoma.,True,Gene promoter identification
11404331,A systematic screen for dominant second-site modifiers of Merlin/NF2 phenotypes reveals an interaction with blistered/DSRF and scribbler.,True,Genetic modifier screening
11432873,Schwannomin isoform-1 interacts with syntenin via PDZ domains.,True,Protein interaction study
11433044,Quantification of splice variants using real-time PCR.,True,Splice variant quantification method
11435472,"Hyperactivation of p21(ras) and the hematopoietic-specific Rho GTPase, Rac2, cooperate to alter the proliferation of neurofibromin-deficient mast cells in vivo and in vitro.",True,Cellular proliferation analysis
11438454,NF1 deletions in S-100 protein-positive and negative cells of sporadic and neurofibromatosis 1 (NF1)-associated plexiform neurofibromas and malignant peripheral nerve sheath tumors.,True,Genetic deletion analysis
11533205,Retroviral integration at the Epi1 locus cooperates with Nf1 gene loss in the progression to acute myeloid leukemia.,True,Retroviral integration model
11535133,Binding of the merlin-I product of the neurofibromatosis type 2 tumour suppressor gene to a novel site in beta-fodrin is regulated by association between merlin domains.,True,Protein binding analysis
11544276,Quantitative effects of Nf1 inactivation on in vivo hematopoiesis.,True,In vivo hematopoiesis quantification
11703924,"The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling.",True,Signaling pathway analysis
11719502,p21-activated kinase links Rac/Cdc42 signaling to merlin.,True,Protein signaling interaction
11727199,"C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme.",True,mRNA editing analysis
11756419,Structural basis for neurofibromatosis type 2. Crystal structure of the merlin FERM domain.,True,Protein structural analysis
11784085,Allele-specific non-CpG methylation of the Nf1 gene during early mouse development.,True,Genetic methylation analysis
11809806,"The neurofibromatosis type 2 gene product, merlin, reverses the F-actin cytoskeletal defects in primary human Schwannoma cells.",True,Cellular cytoskeletal analysis
11896214,NF1 tumor suppressor mRNA is targeted to the cell-cell contact zone in Ca(2+)-induced keratinocyte differentiation.,True,mRNA localization study
11996670,The 4.1/ezrin/radixin/moesin domain of the DAL-1/Protein 4.1B tumour suppressor interacts with 14-3-3 proteins.,True,Protein interaction analysis
12000789,Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse.,True,Mouse meningioma model
12057013,Complex splicing pattern generates great diversity in human NF1 transcripts.,True,Transcript diversity analysis
12077339,Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation.,True,Genetic inactivation model
12082543,Mouse models of neurofibromatosis 1 and 2.,True,Mouse models of disease
12095621,Quantification of NF1 transcripts reveals novel highly expressed splice variants.,True,NF1 transcript quantification
12124168,Thinking beyond the tumor cell: Nf1 haploinsufficiency in the tumor environment.,True,Tumor microenvironment model
12130630,Mutant products of the NF2 tumor suppressor gene are degraded by the ubiquitin-proteasome pathway.,True,Protein degradation pathway
12191989,The motor protein kinesin-1 links neurofibromin and merlin in a common cellular pathway of neurofibromatosis.,True,Protein interaction pathway
12199909,Functional expression of NF1 tumor suppressor protein: association with keratin intermediate filaments during the early development of human epidermis.,True,Protein functional expression
12243339,Inhibition of ras-mediated activator protein 1 activity and cell growth by merlin.,True,Cell growth inhibition method
12393498,Leukemic potential of doubly mutant Nf1 and Wv hematopoietic cells.,True,Genetic interaction model
12469121,Nf1 has an essential role in endothelial cells.,True,Endothelial cell genetic model
12471027,Isolation and characterization of an aggresome determinant in the NF2 tumor suppressor.,True,Protein characterization
12600938,Dynamic regulation of the Ras pathway via proteolysis of the NF1 tumor suppressor.,True,Protein regulation mechanism
12612091,Brain lipid binding protein in axon-Schwann cell interactions and peripheral nerve tumorigenesis.,True,Schwann cell interaction study
12673723,Quinidine impairs proliferation of neurofibromatosis type 2-deficient human malignant mesothelioma cells.,True,Drug proliferation screening
12679023,PDZ tandem of human syntenin: crystal structure and functional properties.,True,Protein structural analysis
12695331,NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions.,True,Cellular junction destabilization model
12730209,Neurofibromatosis type I tumor suppressor neurofibromin regulates neuronal differentiation via its GTPase-activating protein function toward Ras.,True,Neuronal differentiation mechanism
12896975,Merlin links to the cAMP neuronal signaling pathway by anchoring the RIbeta subunit of protein kinase A.,True,Protein signaling interaction
12904481,Aberrant growth and differentiation of oligodendrocyte progenitors in neurofibromatosis type 1 mutants.,True,Oligodendrocyte progenitor model
12946024,Pathological adhesion of primary human schwannoma cells is dependent on altered expression of integrins.,True,Cell adhesion characterization
1358802,The gene for a novel epidermal antigen maps near the neurofibromatosis 1 gene.,True,Genetic mapping reagent
1362901,The role of Gln61 and Glu63 of Ras GTPases in their activation by NF1 and Ras GAP.,True,Molecular interaction analysis
1376554,Immunolocalization of a glycosylphosphatidylinositol-specific phospholipase D in mast cells found in normal tissue and neurofibromatosis lesions.,True,Immunolocalization technique
1376775,SAG: a Schwann cell membrane glycoprotein.,True,Membrane protein characterization
1427886,A radiation hybrid map of the region on human chromosome 22 containing the neurofibromatosis type 2 locus.,True,Radiation hybrid mapping
14523097,The neurofibromatosis 1 gene product neurofibromin regulates pituitary adenylate cyclase-activating polypeptide-mediated signaling in astrocytes.,True,Molecular signaling mechanism
14580336,"Merlin, the product of the Nf2 tumor suppressor gene, is an inhibitor of the p21-activated kinase, Pak1.",True,Protein interaction study
14627667,Identification of recurrent regions of chromosome loss and gain in vestibular schwannomas using comparative genomic hybridisation.,True,Comparative genomic hybridization
14679174,It takes two to tango: mast cell and Schwann cell interactions in neurofibromas.,True,Cell interaction model
14679180,Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/- mast cells.,True,Cell migration mechanism
14679203,Merlin neutralizes the inhibitory effect of Mdm2 on p53.,True,Protein interaction mechanism
14681409,The Unified Medical Language System (UMLS): integrating biomedical terminology.,True,Computational terminology tool
14724565,Role of TC21/R-Ras2 in enhanced migration of neurofibromin-deficient Schwann cells.,True,Cell migration mechanism
14741381,"PKA phosphorylation and 14-3-3 interaction regulate the function of neurofibromatosis type I tumor suppressor, neurofibromin.",True,Protein modification mechanism
1496981,Analysis of chromosome 22 deletions in neurofibromatosis type 2-related tumors.,True,Chromosome deletion analysis
14988005,Neurofibromin is actively transported to the nucleus.,True,"Protein localization mechanism/home/runner/work/nf-research-tools-schema/nf-research-tools-schema/tool_coverage/scripts/screen_publication_titles.py:85: DeprecationWarning: The model 'claude-3-5-haiku-20241022' is deprecated and will reach end-of-life on February 19th, 2026."
14991710,Characterization of chicken Nf2/merlin indicates regulatory roles in cell proliferation and migration.,True,Animal model characterization
15039234,Loss of the nf1 tumor suppressor gene decreases fas antigen expression in myeloid cells.,True,Gene expression analysis
15123692,"Merlin, a tumor suppressor, interacts with transactivation-responsive RNA-binding protein and inhibits its oncogenic activity.",True,Protein interaction mechanism
1519665,Nonradioactive in situ hybridization using digoxigenin-labeled oligonucleotides. Applications to musculoskeletal tissues.,True,In situ hybridization technique
15206577,Gene expression analysis of the lung following paraquat administration in rats using DNA microarray.,True,Gene expression microarray
15240917,Survival of Human Neurofibroma in Immunodeficient Mice and Initial Results of Therapy With Pirfenidone.,True,Patient-derived xenograft model
15255999,"Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR.",True,Gene expression profiling
15446585,Gene expression profiling reveals unique molecular subtypes of Neurofibromatosis Type I-associated and sporadic malignant peripheral nerve sheath tumors.,True,Gene expression profiling
15570216,Targeted gene expression in the chicken eye by in ovo electroporation.,True,Gene expression technique
15598747,Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L.,True,Protein interaction mechanism
15623944,DNA ploidy and chromosome (FISH) pattern analysis of peripheral nerve sheath tumors.,True,Chromosome analysis technique
15647118,Patient-focused measures of functional health status and health-related quality of life in pediatric orthopedics: a case study in measurement selection.,True,Clinical assessment tool
15652750,Role for the epidermal growth factor receptor in neurofibromatosis-related peripheral nerve tumorigenesis.,True,Molecular mechanism study
15659388,Erbin regulates mitogen-activated protein (MAP) kinase activation and MAP kinase-dependent interactions between Merlin and adherens junction protein complexes in Schwann cells.,True,Protein interaction mechanism
15681480,Sensitive detection of deletions of one or more exons in the neurofibromatosis type 2 (NF2) gene by multiplexed gene dosage polymerase chain reaction.,True,Genetic screening technique
15767669,TATA-binding protein (TBP)-like factor (TLF) is a functional regulator of transcription: reciprocal regulation of the neurofibromatosis type 1 and c-fos genes by TLF/TRF2 and TBP.,True,Transcription regulation mechanism
15831594,Methodological issues in longitudinal studies: vestibular schwannoma growth rates in neurofibromatosis 2.,True,Clinical assessment method
15832546,Psychological disturbance and sleep disorders in children with neurofibromatosis type 1.,True,Psychological assessment tool
15840687,NF1 gene loss of heterozygosity and expression analysis in sporadic colon cancer.,True,Gene expression analysis
15849434,Identification of Rab GTPase-activating protein-like protein (RabGAPLP) as a novel Alix/AIP1-interacting protein.,True,Protein interaction mechanism
1587809,Expression of the GTPase activating domain of the neurofibromatosis type 1 (NF1) gene in Escherichia coli and role of the conserved lysine residue.,True,Protein expression technique
15937108,The NF1 tumor suppressor critically regulates TSC2 and mTOR.,True,Molecular signaling mechanism
15988004,Transcriptional repression of the Neurofibromatosis-1 tumor suppressor by the t(8;21) fusion protein.,True,Transcriptional regulation mechanism
16033085,Malignant peripheral nerve sheath tumors (MPNST) in neurofibromatosis type 1 (NF1): diagnostic findings on magnetic resonance images and mutation analysis of the NF1 gene.,True,Imaging and mutation analysis
16036108,Temporally regulated neural crest transcription factors distinguish neuroectodermal tumors of varying malignancy and differentiation.,True,Molecular characterization technique
1605307,Adrenal medullary tumors and iris proliferation in a transgenic mouse model of neurofibromatosis.,True,Transgenic animal model
16061561,Age related shift in the mutation spectra of germline and somatic NF2 mutations: hypothetical role of DNA repair mechanisms.,True,Mutation analysis technique
16082189,Signal therapy of breast cancers by the HDAC inhibitor FK228 that blocks the activation of PAK1 and abrogates the tamoxifen-resistance.,True,Molecular mechanism study
16093333,Sensory neurons from Nf1 haploinsufficient mice exhibit increased excitability.,True,Animal model characterization
16098465,Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma.,True,Molecular mechanism study
16116616,Palindromic AT-rich repeat in the NF1 gene is hypervariable in humans and evolutionarily conserved in primates.,True,Genetic sequence analysis
16117786,Gonosomal mosaicism for a nonsense mutation (R1947X) in the NF1 gene in segmental neurofibromatosis type 1.,True,Genetic mutation analysis
16169856,The neurofibromatosis type 1 gene product neurofibromin enhances cell motility by regulating actin filament dynamics via the Rho-ROCK-LIMK2-cofilin pathway.,True,Molecular mechanism study
16226702,A mouse model for studying therapy-induced cancers.,True,Animal model development
16226708,Therapy-induced malignant neoplasms in Nf1 mutant mice.,True,Animal model development
16267393,The Phosphorylation status of merlin is important for regulating the Ras-ERK pathway.,True,Protein modification mechanism
16314489,Inactivation of NF1 in CNS causes increased glial progenitor proliferation and optic glioma formation.,True,Animal model development
16324214,"Evolution and origin of merlin, the product of the Neurofibromatosis type 2 (NF2) tumor-suppressor gene.",True,Evolutionary analysis technique
16340004,New approaches to the analysis of palindromic sequences from the human genome: evolution and polymorphism of an intronic site at the NF1 locus.,True,Genetic sequence analysis
16374483,Neurofibromatosis type 1 protein and amyloid precursor protein interact in normal human melanocytes and colocalize with melanosomes.,True,Protein interaction mechanism
1639394,A yeast artificial chromosome contig encompassing the type 1 neurofibromatosis gene.,True,Genetic mapping technique
16397625,A novel bipartite phospholipid-binding module in the neurofibromatosis type 1 protein.,True,Protein interaction mechanism
16418572,Sichuan pepper extracts block the PAK1/cyclin D1 pathway and the growth of NF1-deficient cancer xenograft in mice.,True,Xenograft model
16513807,Effect of neurofibromatosis type I mutations on a novel pathway for adenylyl cyclase activation requiring neurofibromin and Ras.,True,Molecular signaling mechanism
16524466,Cognitive dysfunction in NF1 knock-out mice may result from altered vesicular trafficking of APP/DRD3 complex.,True,Animal model characterization
16537381,Mixed-lineage kinase 3 regulates B-Raf through maintenance of the B-Raf/Raf-1 complex and inhibition by the NF2 tumor suppressor protein.,True,Molecular mechanism study
16571745,Temporal control of Rac in Schwann cell-axon interaction is disrupted in NF2-mutant schwannoma cells.,True,Molecular mechanism study
16581517,The tumor suppressors Merlin and Expanded function cooperatively to modulate receptor endocytosis and signaling.,True,Protein interaction mechanism
16619545,Expression of emmprin and matrix metalloproteinases (MMPs) in peripheral nerve sheath tumors: emmprin and membrane-type (MT)1-MMP expressions are associated with malignant potential.,True,Molecular expression analysis
1672744,A polymorphic cDNA probe on chromosome 17q11.2 located within the NF1 gene [D17S376].,True,Genetic mapping technique
16793550,The kelch proteins Gpb1 and Gpb2 inhibit Ras activity via association with the yeast RasGAP neurofibromin homologs Ira1 and Ira2.,True,Molecular interaction mechanism
1679535,A TaqI polymorphism in the human NF1 gene.,True,Genetic polymorphism technique
1679929,A BglII polymorphism in the human NF1 gene.,True,Genetic polymorphism technique
16835260,Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling.,True,Cell interaction mechanism
1684425,A BglII RFLP near the human neurofibromatosis type 1 (NF1) gene.,True,Genetic polymorphism technique
16870183,NF1 mRNA biogenesis: effect of the genomic milieu in splicing regulation of the NF1 exon 37 region.,True,mRNA analysis technique
16894610,Regulation of the neurofibromatosis 2 gene promoter expression during embryonic development.,True,Gene promoter regulation mechanism
16906226,The neurofibromin GAP-related domain rescues endothelial but not neural crest development in Nf1 mice.,True,Animal model development
1696266,Angiogenic and invasive properties of neurofibroma Schwann cells.,True,Cell line characterization
17053831,Hyperactivation of p21ras and PI3K cooperate to alter murine and human neurofibromatosis type 1-haploinsufficient osteoclast functions.,True,Animal model research
17075701,Electrophysiological validation of a human prototype auditory midbrain implant in a guinea pig model.,True,Animal model for medical device
17090653,Beta common receptor inactivation attenuates myeloproliferative disease in Nf1 mutant mice.,True,Animal model research
17210637,"Identification and characterization of putative tumor suppressor NGB, a GTP-binding protein that interacts with the neurofibromatosis 2 protein.",True,Genetic reagent characterization
17215387,Phosphatidylinositol 3-kinase and Akt nonautonomously promote perineurial glial growth in Drosophila peripheral nerves.,True,Genetic model research
17216419,Nf1 expression is dependent on strain background: implications for tumor suppressor haploinsufficiency studies.,True,Animal model research
17295913,Functional analysis of splicing mutations in exon 7 of NF1 gene.,True,Genetic mutation analysis
17548515,Contact-dependent inhibition of EGFR signaling by Nf2/Merlin.,True,Molecular signaling research
17558420,Imatinib mesylate inhibits cell invasion of malignant peripheral nerve sheath tumor induced by platelet-derived growth factor-BB.,True,Drug screening research
17581973,Distinct functional domains of neurofibromatosis type 1 regulate immediate versus long-term memory formation.,True,Genetic model research
17649826,Expression of insulin-like growth-factor-1 receptor (IGF-1R) in peripheral nerve sheath tumors in neurofibromatosis type 1.,True,Molecular marker research
17786186,MMP-13 and p53 in the progression of malignant peripheral nerve sheath tumors.,True,Molecular marker research
1783401,cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product.,True,Genetic reagent development
17868749,Point mutation in the NF2 gene of HEI-193 human schwannoma cells results in the expression of a merlin isoform with attenuated growth suppressive activity.,True,Cell line genetic characterization
17924978,Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations.,True,Animal model development
17962031,Modeling NF2 with human arachnoidal and meningioma cell culture systems: NF2 silencing reflects the benign character of tumor growth.,True,Cell line research tool
18032726,Features of 5'-splice-site efficiency derived from disease-causing mutations and comparative genomics.,True,Genetic mutation analysis
18055911,Deletions of NF1 gene and exons detected by multiplex ligation-dependent probe amplification.,True,Genetic screening method
18057212,Electrical stimulation of the midbrain for hearing restoration: insight into the functional organization of the human central auditory system.,True,Animal model for medical device
18186933,The role of Drosophila Merlin in spermatogenesis.,True,Genetic model research
18188004,Real-time PCR analysis of candidate imprinted genes on mouse chromosome 11 shows balanced expression from the maternal and paternal chromosomes and strain-specific variation in expression levels.,True,Genetic expression analysis
18218617,"Neurofibromatosis type 1 (NF1) tumor suppressor, neurofibromin, regulates the neuronal differentiation of PC12 cells via its associating protein, CRMP-2.",True,Cell line research
18242512,Induction of abnormal proliferation by nonmyelinating schwann cells triggers neurofibroma formation.,True,Animal model research
18242513,The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells.,True,Stem cell model research
18272679,Neurofibromin is required for barrel formation in the mouse somatosensory cortex.,True,Animal model research
18328429,A conditional mouse model for malignant mesothelioma.,True,Animal model development
18367665,Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin.,True,Drug screening research
18371380,Neurofibromatosis-1 regulates neuronal and glial cell differentiation from neuroglial progenitors in vivo by both cAMP- and Ras-dependent mechanisms.,True,Genetic model research
18413802,Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.,True,Drug screening research
18442999,Nf1+/- mice have increased neointima formation via hyperactivation of a Gleevec sensitive molecular pathway.,True,Animal model research
18445079,Altered adhesive structures and their relation to RhoGTPase activation in merlin-deficient Schwannoma.,True,Cellular mechanism research
18451155,Pten haploinsufficiency accelerates formation of high-grade astrocytomas.,True,Animal model research
18483311,Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,True,Drug screening research
18503770,The pathological splicing mutation c.6792C>G in NF1 exon 37 causes a change of tenancy between antagonistic splicing factors.,True,Genetic mutation analysis
18614544,Neurofibromin regulates somatic growth through the hypothalamic-pituitary axis.,True,Animal model research
18632543,Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial.,True,Clinical assessment tool
18632626,Merlin is a potent inhibitor of glioma growth.,True,Molecular mechanism research
18636037,The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary study.,True,Patient-derived xenograft model
18670322,Vestibular schwannoma quantitative polymerase chain reaction expression of estrogen and progesterone receptors.,True,Molecular marker research
18671844,Modelling neurofibromatosis type 1 tibial dysplasia and its treatment with lovastatin.,True,Animal model research
18768391,Pak1 regulates multiple c-Kit mediated Ras-MAPK gain-in-function phenotypes in Nf1+/- mast cells.,True,Genetic model research
18769552,Frequent EGFR Positivity and Overexpression in High-Grade Areas of Human MPNSTs.,True,Molecular marker research
18800150,Mechanisms of loss of heterozygosity in neurofibromatosis type 1-associated plexiform neurofibromas.,True,Genetic mechanism research
18923024,Tumor suppressor schwannomin/merlin is critical for the organization of Schwann cell contacts in peripheral nerves.,True,Cellular mechanism research
18927496,Suppression of proliferation of two independent NF1 malignant peripheral nerve sheath tumor cell lines by the pan-ErbB inhibitor CI-1033.,True,Drug screening research
18931645,Bioluminescent imaging of intracranial vestibular schwannoma xenografts in NOD/SCID mice.,True,Patient-derived xenograft model
18953429,"The neurofibromatosis 2 tumor suppressor gene product, merlin, regulates human meningioma cell growth by signaling through YAP.",True,Molecular mechanism research
18953430,Tissue-specific ablation of Prkar1a causes schwannomas by suppressing neurofibromatosis protein production.,True,Animal model research
18974932,A role for the p53 pathway in the pathology of meningiomas with NF2 loss.,True,Molecular mechanism research
18984156,Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow.,True,Animal model research
18984165,Neurofibromin regulation of ERK signaling modulates GABA release and learning.,True,Molecular mechanism research
18988803,Ras signaling influences permissiveness of malignant peripheral nerve sheath tumor cells to oncolytic herpes.,True,Drug screening research
19016857,Polypyrimidine tract binding protein regulates alternative splicing of an aberrant pseudoexon in NF1.,True,Genetic splicing research tool
1903357,"cDNA sequence and genomic structure of EV12B, a gene lying within an intron of the neurofibromatosis type 1 gene.",True,Genetic sequence characterization
19041782,Nf1 mutation expands an EGFR-dependent peripheral nerve progenitor that confers neurofibroma tumorigenic potential.,True,Animal model of NF1 mutation
19191334,Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation.,True,Microarray analysis tool
19282654,"Tranilast, an anti-allergic drug, down-regulates the growth of cultured neurofibroma cells derived from neurofibromatosis type 1.",True,Cell culture research method
19333415,Drosophila melanogaster as a model organism of brain diseases.,True,Drosophila disease model
19427284,The neurofibroma cell of origin: SKPs expand the playing field.,True,Cell of origin research tool
19427294,Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas.,True,Cell origin and microenvironment model
19430883,Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma.,True,Clinical assessment criteria
19434310,Preliminary study regarding the utility of certain immunohistochemical markers in diagnosing neurofibromas and schwannomas.,True,Immunohistochemical diagnostic tool
19621444,Health-related quality of life measures in genetic disorders: an outcome variable for consideration in clinical trials.,True,Quality of life assessment tool
19710506,Nf1 deficiency cooperates with oncogenic K-RAS to induce acute myeloid leukemia in mice.,True,Animal model of leukemia
19877719,Comparative protein profiling reveals minichromosome maintenance (MCM) proteins as novel potential tumor markers for meningiomas.,True,Protein profiling method
19966217,Cardiac and vascular functions of the zebrafish orthologues of the type I neurofibromatosis gene NFI.,True,Zebrafish disease model
20049725,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene.,True,Genomic analysis tool
20176786,Bioluminescent approaches for measuring tumor growth in a mouse model of neurofibromatosis.,True,Bioluminescent imaging tool
20187887,"Application of the International Classification of Functioning, Disability and Health in children with neurofibromatosis type 1: a review.",True,Clinical assessment tool
20195187,Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis.,True,Cell culture research method
20233966,Use of chromosome engineering to model a segmental deletion of chromosome band 7q22 found in myeloid malignancies.,True,Chromosome engineering model
20428190,NF-1Score: a prediction score for internal neurofibromas in neurofibromatosis-1.,True,Clinical prediction score
20511180,ErbB/HER receptor activation and preclinical efficacy of lapatinib in vestibular schwannoma.,True,Preclinical drug efficacy study
20551058,Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1.,True,Animal disease model
20600672,Ultrastructural characterization of the optic pathway in a mouse model of neurofibromatosis-1 optic glioma.,True,Ultrastructural characterization model
20606732,CD44 and p53 immunoexpression patterns in NF1 neoplasms - indicators of malignancy and infiltration.,True,Immunohistochemical diagnostic tool
20643348,The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals.,True,Molecular mechanism research tool
20643380,Targeted treatments for cognitive and neurodevelopmental disorders in tuberous sclerosis complex.,True,Targeted treatment research
20668197,A distinct set of Drosophila brain neurons required for neurofibromatosis type 1-dependent learning and memory.,True,Drosophila brain neuron model
20668201,Merlin inhibits neurite outgrowth in the CNS.,True,Neuroscience research mechanism
20675406,Nf2/Merlin controls progenitor homeostasis and tumorigenesis in the liver.,True,Genetic model of progenitor homeostasis
20680410,The role of neurofibromin in N-Ras mediated AP-1 regulation in malignant peripheral nerve sheath tumors.,True,Molecular mechanism research
20686603,The 4q12 amplicon in malignant peripheral nerve sheath tumors: consequences on gene expression and implications for sunitinib treatment.,True,Gene expression analysis tool
20699653,Analysis of steroid hormone effects on xenografted human NF1 tumor schwann cells.,True,Xenograft cell model
20713513,Merlin in organ size control and tumorigenesis: Hippo versus EGFR?,True,Molecular mechanism research
20739432,Gene expression analysis identifies potential biomarkers of neurofibromatosis type 1 including adrenomedullin.,True,Gene expression biomarker research
20818339,MicroRNA expression profiling in benign (sporadic and hereditary) and recurring adrenal pheochromocytomas.,True,MicroRNA expression profiling
20826448,Reduced striatal dopamine underlies the attention system dysfunction in neurofibromatosis-1 mutant mice.,True,Animal model of neurological dysfunction
20856158,MicroRNA-21 overexpression contributes to vestibular schwannoma cell proliferation and survival.,True,Molecular mechanism research
20858602,Oligodendrocyte progenitor cell numbers and migration are regulated by the zebrafish orthologs of the NF1 tumor suppressor gene.,True,Zebrafish genetic model
20876733,Neurofibromatosis-1 regulates neuroglial progenitor proliferation and glial differentiation in a brain region-specific manner.,True,Neuroglial progenitor research model
20890305,Regulation of mixed lineage kinase 3 is required for Neurofibromatosis-2-mediated growth suppression in human cancer.,True,Molecular mechanism research
21031597,Dissecting loss of heterozygosity (LOH) in neurofibromatosis type 1-associated neurofibromas: Importance of copy neutral LOH.,True,Genetic loss of heterozygosity analysis
2105641,Flanking markers bracket the neurofibromatosis type 2 (NF2) gene on chromosome 22.,True,Genetic mapping research
21072183,p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2.,True,Cell transformation model
21074722,"The NF2 tumor suppressor, Merlin, regulates epidermal development through the establishment of a junctional polarity complex.",True,Molecular mechanism research
21084862,Merlin's tumor suppression linked to inhibition of the E3 ubiquitin ligase CRL4 (DCAF1).,True,Molecular mechanism research
21111000,A novel imaging-compatible sciatic nerve schwannoma model.,True,Imaging-compatible animal model
21157378,Neurofibromatosis-1 heterozygosity increases microglia in a spatially and temporally restricted pattern relevant to mouse optic glioma formation and growth.,True,Mouse genetic model
2117565,The human homolog of murine Evi-2 lies between two von Recklinghausen neurofibromatosis translocations.,True,Genetic mapping research
21182951,Schwannomin/merlin promotes Schwann cell elongation and influences myelin segment length.,True,Molecular mechanism research
2119504,Genetic and physical map of the von Recklinghausen neurofibromatosis (NF1) region on chromosome 17.,True,Genetic mapping research
21196210,Genetic basis of tumorigenesis in NF1 malignant peripheral nerve sheath tumors.,True,Genetic tumorigenesis research
21199799,Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant mice.,True,Animal radiation model
2121371,The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins.,True,Genetic mechanism research
21216928,Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytes.,True,Genetically engineered mouse model
21224727,Autophagy blockade enhances HDAC inhibitors' pro-apoptotic effects: potential implications for the treatment of a therapeutic-resistant malignancy.,True,Drug mechanism research
21255467,SMARCB1/INI1 germline mutations contribute to 10% of sporadic schwannomatosis.,True,Genetic mutation analysis
21324880,Comparative methylome analysis of benign and malignant peripheral nerve sheath tumors.,True,Comparative methylome analysis
21352477,Motor deficits in neurofibromatosis type 1 mice: the role of the cerebellum.,True,Animal behavioral model
21383154,Missense mutations in the NF2 gene result in the quantitative loss of merlin protein and minimally affect protein intrinsic function.,True,Molecular mechanism research
21402777,FERM domain phosphoinositide binding targets merlin to the membrane and is essential for its growth-suppressive function.,True,Molecular mechanism research
2142531,Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis.,True,Genetic mutation analysis
21439418,Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model.,True,Animal model of bone pathology
21454924,"miRNA signature of schwannomas: possible role(s) of ""tumor suppressor"" miRNAs in benign tumors.",True,MicroRNA signature research
21460792,Orthotopic xenografting of human luciferase-tagged malignant peripheral nerve sheath tumor cells for in vivo testing of candidate therapeutic agents.,True,Xenograft model for drug testing
21465658,Multiple increased osteoclast functions in individuals with neurofibromatosis type 1.,True,Cellular function research
21478499,Neurofibromin (Nf1) is required for skeletal muscle development.,True,Genetic muscle development model
21479127,Succinate Dehydrogenase Subunit B (SDHB) Is Expressed in Neurofibromatosis 1-Associated Gastrointestinal Stromal Tumors (Gists): Implications for the SDHB Expression Based Classification of Gists.,True,Molecular expression analysis
21551250,Susceptible stages in Schwann cells for NF1-associated plexiform neurofibroma development.,True,Cellular developmental model
21563229,Effects of splicing mutations on NF2-transcripts: transcript analysis and information theoretic predictions.,True,Genetic transcript analysis
21596366,Loss of BRCC3 deubiquitinating enzyme leads to abnormal angiogenesis and is associated with syndromic moyamoya.,True,Molecular mechanism research
21636709,Control of proliferation in astrocytoma cells by the receptor tyrosine kinase/PI3K/AKT signaling axis and the use of PI-103 and TCN as potential anti-astrocytoma therapies.,True,Molecular signaling research
21659924,"ErbB expression, activation, and inhibition with lapatinib and tyrphostin (AG825) in human vestibular schwannomas.",True,Molecular mechanism research
21666496,Comparative characterization of the human and mouse third ventricle germinal zones.,True,Comparative developmental model
2167436,"Evi-2, a common integration site involved in murine myeloid leukemogenesis.",True,Genetic integration research
21681782,Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype.,True,Genetically engineered mouse model
21686274,Inhibition of Cdc42-mediated activation of mixed lineage kinase 3 by the tumor suppressor protein merlin.,True,Molecular mechanism research
21697395,Discovery of a small molecule targeting IRA2 deletion in budding yeast and neurofibromin loss in malignant peripheral nerve sheath tumor cells.,True,Drug discovery research
21726432,MIA is a potential biomarker for tumour load in neurofibromatosis type 1.,True,Biomarker research
21727212,Nilotinib alone or in combination with selumetinib is a drug candidate for neurofibromatosis type 2.,True,Drug candidate research
21748792,Hyperactivation of mTOR critically regulates abnormal osteoclastogenesis in neurofibromatosis Type 1.,True,Cellular mechanism research
21750658,Multistep phosphorylation by oncogenic kinases enhances the degradation of the NF2 tumor suppressor merlin.,True,Molecular mechanism research
21778190,"AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas.",True,Drug mechanism research
21855613,Genetically engineered mouse models shed new light on the pathogenesis of neurofibromatosis type I-related neoplasms of the peripheral nervous system.,True,Genetically engineered mouse models
21878642,KIBRA protein phosphorylation is regulated by mitotic kinase aurora and protein phosphatase 1.,True,Molecular mechanism research
21896734,Neurofibromatosis-1 regulates mTOR-mediated astrocyte growth and glioma formation in a TSC/Rheb-independent manner.,True,Animal model research
21903164,Neurofibromatosis-1 heterozygosity impairs CNS neuronal morphology in a cAMP/PKA/ROCK-dependent manner.,True,Animal model research
21931722,The probable cell of origin of NF1- and PDGF-driven glioblastomas.,True,Cell line research
21949590,ALTERED CALCIUM CURRENTS AND AXONAL GROWTH IN Nf1 HAPLOINSUFFICIENT MICE.,True,Animal model research
21949657,The receptor tyrosine kinase Alk controls neurofibromin functions in Drosophila growth and learning.,True,Genetic model in Drosophila
21963652,PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice.,True,Animal model for PET imaging
21980365,The haploinsufficient hematopoietic microenvironment is critical to the pathological fracture repair in murine models of neurofibromatosis type 1.,True,Animal model research
22105171,Valosin-containing protein and neurofibromin interact to regulate dendritic spine density.,True,Molecular interaction research
22384355,The SPRED1 Variants Repository for Legius Syndrome.,True,Genetic variant repository
22433254,Lovastatin regulates brain spontaneous low-frequency brain activity in neurofibromatosis type 1.,True,Drug effect on brain activity
22449146,From neurodevelopment to neurodegeneration: the interaction of neurofibromin and valosin-containing protein/p97 in regulation of dendritic spine formation.,True,Molecular interaction research
22493273,Neurofibromatosis-like phenotype in Drosophila caused by lack of glucosylceramide extension.,True,Genetic model in Drosophila
22550514,Skin-derived precursor cells as an in vitro modelling tool for the study of type 1 neurofibromatosis.,True,Cell culture model development
22821737,The Learning Disabilities Network (LeaDNet): using neurofibromatosis type 1 (NF1) as a paradigm for translational research.,True,Research network development
22901811,ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.,True,Neural progenitor research
22916147,Applying microsatellite multiplex PCR analysis (MMPA) for determining allele copy-number status and percentage of normal cells within tumors.,True,Molecular analysis technique
22961690,Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas.,True,Clinical drug trial
23055477,Neurofibromatosis type 1: modeling CNS dysfunction.,True,CNS dysfunction modeling
23071067,Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms.,True,Animal model development
23087000,Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice.,True,Animal model of cancer
23213372,Stability of the tumor suppressor merlin depends on its ability to bind paxillin LD3 and associate with β1 integrin and actin at the plasma membrane.,True,Molecular biology research tool
23221337,Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice.,True,Animal model research
23221339,Normal hematopoiesis and neurofibromin-deficient myeloproliferative disease require Erk.,True,Molecular signaling research
23221341,MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors.,True,Therapeutic drug screening
23222849,Somatic neurofibromatosis type 1 (NF1) inactivation characterizes NF1-associated pilocytic astrocytoma.,True,Genetic characterization method
23225063,Dopamine deficiency underlies learning deficits in neurofibromatosis-1 mice.,True,Animal model behavioral research
23239959,Partial Blindness to Submicron Topography in NF1 Haploinsufficient Cultured Fibroblasts Indicates a New Function of Neurofibromin in Regulation of Mechanosensoric.,True,Cell culture research method
23244685,Molecular heterogeneity in malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1.,True,Molecular characterization method
23267122,"Neurofibromatosis type 2 protein, NF2: an uncoventional cell cycle regulator.",True,Molecular biology research
23268719,Isobutylhydroxyamides from the pericarp of Nepalese Zanthoxylum armatum inhibit NF1-defective tumor cell line growth.,True,Cell line drug screening
23308224,"Neurofibromatosis type 2 tumor suppressor protein, NF2, induces proteasome-mediated degradation of JC virus T-antigen in human glioblastoma.",True,Molecular mechanism research
23312374,Modeling cognitive dysfunction in neurofibromatosis-1.,True,Cognitive modeling research
23318430,EGFR-STAT3 signaling promotes formation of malignant peripheral nerve sheath tumors.,True,Molecular signaling research
23328114,Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.,True,Genomic analysis method
23348505,"Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO.",True,Genomic screening method
23356716,Miniaturized handheld confocal microscopy identifies focal brain invasion in a mouse model of aggressive meningioma.,True,Imaging research tool
23358504,Integrated proteomics identified novel activation of dynein IC2-GR-COX-1 signaling in neurofibromatosis type I (NF1) disease model cells.,True,Proteomics research method
23406822,"Gyrification, cortical and subcortical morphometry in neurofibromatosis type 1: an uneven profile of developmental abnormalities.",True,Neuroimaging research method
23412344,Depletion of the novel p53-target gene carnitine palmitoyltransferase 1C delays tumor growth in the neurofibromatosis type I tumor model.,True,Tumor model research
23413263,Loss of SOX10 function contributes to the phenotype of human Merlin-null schwannoma cells.,True,Molecular characterization method
23423222,RAS/MEK-independent gene expression reveals BMP2-related malignant phenotypes in the Nf1-deficient MPNST.,True,Genetic expression research
23424002,Reduced microglial CX3CR1 expression delays neurofibromatosis-1 glioma formation.,True,Animal model research
23432799,"Development of the adult PedsQL™ neurofibromatosis type 1 module: initial feasibility, reliability and validity.",True,Clinical assessment tool development
23434321,CXCR4/CXCL12 mediate autocrine cell- cycle progression in NF1-associated malignant peripheral nerve sheath tumors.,True,Molecular signaling research
23446537,"[Quality of life in children with neurofibromatosis type 1, based on their mothers' reports].",True,Quality of life assessment tool
23457304,Platelet-derived growth factor-BB activates calcium/calmodulin-dependent and -independent mechanisms that mediate Akt phosphorylation in the neurofibromin-deficient human Schwann cell line ST88-14.,True,Cell line signaling research
23475878,An unholy alliance: cooperation between BRAF and NF1 in melanoma development and BRAF inhibitor resistance.,True,Molecular mechanism research
23487764,NMR-based functional profiling of RASopathies and oncogenic RAS mutations.,True,Computational research tool
23535903,"Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",True,Molecular signaling research
23555837,Genetic interactions between neurofibromin and endothelin receptor B in mice.,True,Animal model genetic research
23583712,Neurofibromin interacts with the cytoplasmic Dynein Heavy Chain 1 in melanosomes of human melanocytes.,True,Molecular interaction research
23685747,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.,True,Genetic screening method
23714726,Therapeutic potential of HSP90 inhibition for neurofibromatosis type 2.,True,Drug discovery research
23723300,Genotype-specific abnormalities in mitochondrial function associate with distinct profiles of energy metabolism and catecholamine content in pheochromocytoma and paraganglioma.,True,Molecular characterization method
23749527,Extending the convergence of canonical WNT signaling and classic cancer pathways for treatment of malignant peripheral nerve sheath tumors.,True,Molecular pathway research
23762458,Motivational disturbances and effects of L-dopa administration in neurofibromatosis-1 model mice.,True,Animal model behavioral research
23848554,MicroRNAome profiling in benign and malignant neurofibromatosis type 1-associated nerve sheath tumors: evidences of PTEN pathway alterations in early NF1 tumorigenesis.,True,MicroRNA profiling method
23858101,NF1 deletion generates multiple subtypes of soft-tissue sarcoma that respond to MEK inhibition.,True,Animal model drug screening
23863460,Hyperactive Ras/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient mice.,True,Animal model research
23863479,Tumor suppressor Nf2 limits expansion of the neural progenitor pool by inhibiting Yap/Taz transcriptional coactivators.,True,Molecular mechanism research
23907387,An integrative characterization of recurrent molecular aberrations in glioblastoma genomes.,True,Genomic characterization method
23928514,Natural compounds as potential treatments of NF2-deficient schwannoma and meningioma: cucurbitacin D and goyazensolide.,True,Drug discovery research
23934191,LIM domain kinases as potential therapeutic targets for neurofibromatosis type 2.,True,Potential therapeutic target research
23960073,"FRAX597, a small molecule inhibitor of the p21-activated kinases, inhibits tumorigenesis of neurofibromatosis type 2 (NF2)-associated Schwannomas.",True,Drug screening research
24012335,Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2.,True,Molecular mechanism research
24035394,Nf1 loss and Ras hyperactivation in oligodendrocytes induce NOS-driven defects in myelin and vasculature.,True,Animal model research
24040940,Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.,True,Drug resistance research method
24065580,Prevalence of Sleep Disturbances in Children With Neurofibromatosis Type 1.,True,Clinical assessment tool
24101736,Detection of tumor progression in optic pathway glioma with and without neurofibromatosis type 1.,True,Tumor progression imaging method
24132643,EZH2-miR-30d-KPNB1 pathway regulates malignant peripheral nerve sheath tumour cell survival and tumourigenesis.,True,Molecular mechanism research
24189137,Succinate-to-fumarate ratio as a new metabolic marker to detect the presence of SDHB/D-related paraganglioma: initial experimental and ex vivo findings.,True,Metabolic marker research
24197987,Vision specific quality of life in children with optic pathway gliomas.,True,Quality of life assessment tool
24211110,Ras-Mek-Erk signaling regulates Nf1 heterozygous neointima formation.,True,Animal model signaling research
24213576,PPARβ/δ promotes HRAS-induced senescence and tumor suppression by potentiating p-ERK and repressing p-AKT signaling.,True,Molecular mechanism research
24232507,Neuregulin-1 overexpression and Trp53 haploinsufficiency cooperatively promote de novo malignant peripheral nerve sheath tumor pathogenesis.,True,Animal model tumor research
24249801,Achieving consensus for clinical trials: the REiNS International Collaboration.,True,Clinical trial consensus method
24249802,Functional outcome measures for NF1-associated optic pathway glioma clinical trials.,True,Clinical outcome measure development
24249804,Recommendations for imaging tumor response in neurofibromatosis clinical trials.,True,Imaging research method
24249806,Patient-reported outcomes in neurofibromatosis and schwannomatosis clinical trials.,True,Patient-reported outcome tool
24259290,Inhibition of SIRT2 in merlin/NF2-mutant Schwann cells triggers necrosis.,True,Molecular mechanism research
24261697,High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression.,True,Molecular characterization method
24285727,Preclinical therapeutic efficacy of a novel pharmacologic inducer of apoptosis in malignant peripheral nerve sheath tumors.,True,Drug discovery research
24295733,Rapamycin improves sociability in the BTBR T(+)Itpr3(tf)/J mouse model of autism spectrum disorders.,True,Animal model behavioral research
24297905,Regulation of Son of sevenless by the membrane-actin linker protein ezrin.,True,Molecular interaction research
24309211,Neuronal merlin influences ERBB2 receptor expression on Schwann cells through neuregulin 1 type III signalling.,True,Molecular mechanism research
24336571,Genome-scale CRISPR-Cas9 knockout screening in human cells.,True,CRISPR screening method
24346802,"Evaluation of Bcl-2, Bcl-x and cleaved caspase-3 in malignant peripheral nerve sheath tumors and neurofibromas.",True,Molecular marker analysis
24375753,Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1.,True,Animal model of neuronal dysfunction
24414536,mTORC1 inhibition delays growth of neurofibromatosis type 2 schwannoma.,True,Therapeutic drug targeting
24431436,Neurofibromin is the major ras inactivator in dendritic spines.,True,Molecular mechanism research
24465906,"Multiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1.",True,Animal model of bone fragility
24470552,Treatment of orthotopic malignant peripheral nerve sheath tumors with oncolytic herpes simplex virus.,True,Oncolytic virus therapeutic model
24500418,"Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas.",True,Clinical trial with therapeutic intervention
24506781,Exon-skipping antisense oligonucleotides to correct missplicing in neurogenetic diseases.,True,Antisense oligonucleotide genetic reagent
24558021,Proteomic screening identifies a YAP-driven signaling network linked to tumor cell proliferation in human schwannomas.,True,Proteomic screening method
24595234,In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.,True,In vivo functional genetic analysis
24619350,Longitudinal evaluation of quality of life in 288 patients with neurofibromatosis 2.,True,Longitudinal quality of life assessment tool
24676424,Neurofibromatosis type 1 gene mutation analysis using sequence capture and high-throughput sequencing.,True,Genetic mutation analysis method
24681606,Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity.,True,Genetic mouse model
24686726,Activation of Sonic hedgehog signaling in neural progenitor cells promotes glioma development in the zebrafish optic pathway.,True,Zebrafish disease model
24719295,Maximizing bone formation in posterior spine fusion using rhBMP-2 and zoledronic acid in wild type and NF1 deficient mice.,True,Animal model with therapeutic intervention
24753394,Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas.,True,Clinical drug trial
24815379,Application of COLD-PCR for improved detection of NF2 mosaic mutations.,True,Mutation detection method
24817309,Nf2/Merlin controls spinal cord neural progenitor function in a Rac1/ErbB2-dependent manner.,True,Genetic mouse model
24832557,Trp53 haploinsufficiency modifies EGFR-driven peripheral nerve sheath tumorigenesis.,True,Genetic mouse model
2491775,Genetic analysis of eight loci tightly linked to neurofibromatosis 1.,True,Genetic linkage mapping
2491777,Genetic linkage mapping of chromosome 17 markers and neurofibromatosis type I.,True,Genetic linkage mapping
2491778,Flanking markers for the gene causing von Recklinghausen neurofibromatosis (NF1).,True,Genetic marker identification
2491779,A refined genetic map of the region of chromosome 17 surrounding the von Recklinghausen neurofibromatosis (NF1) gene.,True,Genetic mapping
2491781,Close flanking markers for neurofibromatosis type I (NF1).,True,Genetic marker identification
2491782,"Linkage analysis of neurofibromatosis type I, using chromosome 17 DNA markers.",True,Genetic linkage analysis
2491783,Physical mapping of the von Recklinghausen neurofibromatosis region on chromosome 17.,True,Physical mapping method
2491784,Multipoint linkage analysis in neurofibromatosis type I: an international collaboration.,True,Multipoint linkage analysis
2491785,"The order of loci in the pericentric region of chromosome 17, based on evidence from physical and genetic breakpoints.",True,Genetic mapping method
24932921,Neurofibromin deficiency-associated transcriptional dysregulation suggests a novel therapy for tibial pseudoarthrosis in NF1.,True,Transcriptional dysregulation analysis
24958239,SVA retrotransposon insertion-associated deletion represents a novel mutational mechanism underlying large genomic copy number changes with non-recurrent breakpoints.,True,Genomic mutation mechanism
24997609,"Asfotase-α improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1.",True,Animal model with therapeutic intervention
25043591,Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.,True,Animal model with therapeutic intervention
25074460,Neurofibromatosis type 1 molecular diagnosis: what can NGS do for you when you have a large gene with loss of function mutations?,True,Genetic sequencing method
25079666,Primary culture of human vestibular schwannomas.,True,Primary cell culture method
25113746,A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formation.,True,Murine disease model
25184332,Heat hyperalgesia and mechanical hypersensitivity induced by calcitonin gene-related peptide in a mouse model of neurofibromatosis.,True,Animal pain model
25246427,The impact of coexisting genetic mutations on murine optic glioma biology.,True,Genetic mouse model
25274808,Hippocampal dysregulation of neurofibromin-dependent pathways is associated with impaired spatial learning in engrailed 2 knock-out mice.,True,Animal behavioral model
25289889,Combinatorial therapy with tamoxifen and trifluoperazine effectively inhibits malignant peripheral nerve sheath tumor growth by targeting complementary signaling cascades.,True,Drug combination therapy screening
25325900,The use of next-generation sequencing in molecular diagnosis of neurofibromatosis type 1: a validation study.,True,Genetic sequencing validation
25329635,Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.,True,Genetic modifier analysis
25335493,Expanding the mutational spectrum of LZTR1 in schwannomatosis.,True,Genetic mutation spectrum
25336744,The tumor suppressor Nf2 regulates corpus callosum development by inhibiting the transcriptional coactivator Yap.,True,Developmental mouse model
25340526,Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivo.,True,Drug screening method
25360213,A chemical biology approach identified PI3K as a potential therapeutic target for neurofibromatosis type 2.,True,Chemical biology screening
25367036,NF1 regulation of RAS/ERK signaling is required for appropriate granule neuron progenitor expansion and migration in cerebellar development.,True,Developmental mouse model
25377441,Development and validation of the English Pain Interference Index and Pain Interference Index-Parent report.,True,"Pain assessment tool development/home/runner/work/nf-research-tools-schema/nf-research-tools-schema/tool_coverage/scripts/screen_publication_titles.py:85: DeprecationWarning: The model 'claude-3-5-haiku-20241022' is deprecated and will reach end-of-life on February 19th, 2026."
25433207,Nf2-Yap signaling controls the expansion of DRG progenitors and glia during DRG development.,True,Developmental mouse model
25437375,"Abnormal relationship between GABA, neurophysiology and impulsive behavior in neurofibromatosis type 1.",True,Neurophysiological research method
25452392,Evidence of polyclonality in neurofibromatosis type 2-associated multilobulated vestibular schwannomas.,True,Molecular characterization technique
25475340,Validity and interexaminer reliability of a new method to quantify skin neurofibromas of neurofibromatosis 1 using paper frames.,True,Clinical assessment tool development
25480913,Mutations in LZTR1 add to the complex heterogeneity of schwannomatosis.,True,Genetic mutation analysis
25483400,Nf1 regulates alcohol dependence-associated excessive drinking and gamma-aminobutyric acid release in the central amygdala in mice and is associated with alcohol dependence in humans.,True,Animal model research
2551169,Transplacental induction of peripheral nervous tumor in the Syrian golden hamster by N-nitroso-N-ethylurea. A new animal model for von Recklinghausen's neurofibromatosis.,True,Animal model development
25517743,NF GEMMs already! The power and promise of mouse tumor models.,True,Genetic mouse model research
25534823,Akt- or MEK-mediated mTOR inhibition suppresses Nf1 optic glioma growth.,True,Molecular pathway research
25535838,Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,True,Animal model research
25549701,Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.,True,Genetic sequencing method
25551830,Soluble AXL: a possible circulating biomarker for neurofibromatosis type 1 related tumor burden.,True,Biomarker identification
25557241,Outcomes of preimplantation genetic diagnosis in neurofibromatosis type 1.,True,Genetic screening tool
25596744,Group I Paks as therapeutic targets in NF2-deficient meningioma.,True,Potential therapeutic screening
2562822,Fine structure DNA mapping studies of the chromosomal region harboring the genetic defect in neurofibromatosis type I.,True,Genetic mapping technique
25639352,Neural Crest-Specific TSC1 Deletion in Mice Leads to Sclerotic Craniofacial Bone Lesion.,True,Animal model research
25692621,Interplay between VEGF-A and cMET signaling in human vestibular schwannomas and schwann cells.,True,Molecular signaling research
2573276,Refined physical and genetic mapping of the NF1 region on chromosome 17.,True,Genetic mapping technique
25772366,Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.,True,Cancer stem cell model
25788518,Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learning.,True,Molecular function research
25851896,Preclinical assessment of the anticancer drug response of plexiform neurofibroma tissue using primary cultures.,True,Primary cell culture development
25877069,Establishment of immortalized murine mesothelial cells and a novel mesothelioma cell line.,True,Cell line development
25884485,Evaluation of copy number variation and gene expression in neurofibromatosis type-1-associated malignant peripheral nerve sheath tumours.,True,Genetic variation analysis
25887585,NMF-mGPU: non-negative matrix factorization on multi-GPU systems.,True,Computational tool development
25893273,High spatial resolution imaging mass spectrometry of human optic nerve lipids and proteins.,True,Imaging mass spectrometry technique
25917016,"Nf1 Haploinsufficiency Alters Myeloid Lineage Commitment and Function, Leading to Deranged Skeletal Homeostasis.",True,Animal model research
25917366,HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1.,True,Potential therapeutic target research
25946318,Classic Ras Proteins Promote Proliferation and Survival via Distinct Phosphoproteome Alterations in Neurofibromin-Null Malignant Peripheral Nerve Sheath Tumor Cells.,True,Molecular pathway research
25962619,"ADHD-associated dopamine transporter, latrophilin and neurofibromin share a dopamine-related locomotor signature in Drosophila.",True,Animal model research
25963359,Auditory Rehabilitation in Rhesus Macaque Monkeys (Macaca mulatta) with Auditory Brainstem Implants.,True,Animal model research
26000738,Monoallelic loss of the imprinted gene Grb10 promotes tumor formation in irradiated Nf1+/- mice.,True,Animal model research
26039236,Hyperactive RAS/PI3-K/MAPK Signaling Cascade in Migration and Adhesion of Nf1 Haploinsufficient Mesenchymal Stem/Progenitor Cells.,True,Cellular mechanism research
26066488,A Systematic Assessment of Accuracy in Detecting Somatic Mosaic Variants by Deep Amplicon Sequencing: Application to NF2 Gene.,True,Genetic sequencing method
26073082,Runx1 contributes to neurofibromatosis type 1 neurofibroma formation.,True,Molecular mechanism research
26073604,The SWI/SNF Subunit INI1 Contains an N-Terminal Winged Helix DNA Binding Domain that Is a Target for Mutations in Schwannomatosis.,True,Molecular characterization technique
26150484,In vitro modeling of hyperpigmentation associated to neurofibromatosis type 1 using melanocytes derived from human embryonic stem cells.,True,In vitro cell model development
26190969,"In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome.",True,Animal model research
26219339,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,True,High-throughput screening method
26258444,Merlin Isoforms 1 and 2 Both Act as Tumour Suppressors and Are Required for Optimal Sperm Maturation.,True,Molecular characterization research
26272820,Neurofibromatosis-1 regulation of neural stem cell proliferation and multilineage differentiation operates through distinct RAS effector pathways.,True,Stem cell research method
26344136,NF2/Merlin is required for the axial pattern formation in the Xenopus laevis embryo.,True,Animal model research
26344771,Mutational Analysis of Ionizing Radiation Induced Neoplasms.,True,Mutational analysis technique
26461061,"Targeted NF1 cancer therapeutics with multiple modes of action: small molecule hormone-like agents resembling the natural anticancer metabolite, 2-methoxyoestradiol.",True,Potential therapeutic screening
26478990,A novel diagnostic method to detect truncated neurofibromin in neurofibromatosis 1.,True,Diagnostic method development
26490262,Nuclear import mechanism of neurofibromin for localization on the spindle and function in chromosome congression.,True,Molecular localization research
26509978,Functional Analysis of Mutations in Exon 9 of NF1 Reveals the Presence of Several Elements Regulating Splicing.,True,Genetic splicing analysis
26530423,Chemically Induced Oncogenesis in the Peripheral Nervous System Is Suppressed in Congenic BDIX.BDIV-Mss1 and -Mss7 Rats.,True,Animal model research
26536237,Anaplastic Lymphoma Kinase Acts in the Drosophila Mushroom Body to Negatively Regulate Sleep.,True,Animal model research
26549023,"The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors.",True,Potential therapeutic target research
26554010,Anti-VEGF treatment improves neurological function and augments radiation response in NF2 schwannoma model.,True,Animal model research
26558359,A novel genetic- and cell-based tool for assessing the efficacy and toxicity of anticancer drugs in vitro.,True,Drug screening method
26657314,Immortalized Human Schwann Cell Lines Derived From Tumors of Schwannomatosis Patients.,True,Cell line development
26658687,RNAi-nanoparticulate manipulation of gene expression as a new functional genomics tool in the liver.,True,RNAi nanoparticle gene manipulation tool
26740486,The Challenge of Cancer Genomics in Rare Nervous System Neoplasms: Malignant Peripheral Nerve Sheath Tumors as a Paradigm for Cross-Species Comparative Oncogenomics.,True,Comparative oncogenomics computational tool
26740548,Nf1+/- monocytes/macrophages induce neointima formation via CCR2 activation.,True,Animal model (Nf1+/- monocytes)
26822862,Capturing the wide variety of impaired fracture healing phenotypes in Neurofibromatosis Type 1 with eight key factors: a computational study.,True,Computational modeling tool
26840085,Dual mTORC1/2 inhibition induces anti-proliferative effect in NF1-associated plexiform neurofibroma and malignant peripheral nerve sheath tumor cells.,True,Drug screening method
26861207,Feedback activation of neurofibromin terminates growth factor-induced Ras activation.,True,Molecular signaling mechanism
26883872,3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma.,True,3D imaging mass spectrometry tool
26896440,Neurofibromin Loss of Function Drives Excessive Grooming in Drosophila.,True,Drosophila animal model
26904939,Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.,True,Insertional mutagenesis screening
26908603,NF1 germline mutation differentially dictates optic glioma formation and growth in neurofibromatosis-1.,True,Genetic mutation analysis
27021207,Acceptance and commitment therapy in youth with neurofibromatosis type 1 (NF1) and chronic pain and their parents: A pilot study of feasibility and preliminary efficacy.,True,Clinical assessment tool (therapy feasibility)
27078850,Whole exome sequencing of urachal adenocarcinoma reveals recurrent NF1 mutations.,True,Whole exome sequencing method
27081657,A randomized placebo-controlled lovastatin trial for neurobehavioral function in neurofibromatosis I.,True,Clinical trial with assessment tool
27103823,Triterpenoid saponin flaccidoside II from Anemone flaccida triggers apoptosis of NF1-associated malignant peripheral nerve sheath tumors via the MAPK-HO-1 pathway.,True,Drug screening method
27159396,Cotargeting MNK and MEK kinases induces the regression of NF1-mutant cancers.,True,Drug targeting computational method
27216189,YAP Mediates Tumorigenesis in Neurofibromatosis Type 2 by Promoting Cell Survival and Proliferation through a COX-2-EGFR Signaling Axis.,True,Molecular signaling mechanism
27285107,Merlin inhibits Wnt/β-catenin signaling by blocking LRP6 phosphorylation.,True,Molecular signaling mechanism
27313208,The neurofibromin recruitment factor Spred1 binds to the GAP related domain without affecting Ras inactivation.,True,Molecular protein interaction study
27345717,"Merlin, a regulator of Hippo signaling, regulates Wnt/β-catenin signaling.",True,Molecular signaling mechanism
27363027,Crizotinib inhibits NF2-associated schwannoma through inhibition of focal adhesion kinase 1.,True,Drug screening method
27385209,"Co-expression modules of NF1, PTEN and sprouty enable distinction of adult diffuse gliomas according to pathway activities of receptor tyrosine kinases.",True,Computational pathway analysis tool
27418650,Stat5 is critical for the development and maintenance of myeloproliferative neoplasm initiated by Nf1 deficiency.,True,Animal model (Nf1 deficiency)
27458360,COMT Val(158)Met Polymorphism Is Associated with Verbal Working Memory in Neurofibromatosis Type 1.,True,Genetic polymorphism analysis
27467574,Neuron-Specific Deletion of the Nf2 Tumor Suppressor Impairs Functional Nerve Regeneration.,True,Animal model (neuron-specific deletion)
27527646,Neurocognitive outcomes in neurofibromatosis clinical trials: Recommendations for the domain of attention.,True,Clinical trial recommendation tool
27527648,Patient-reported outcomes of pain and physical functioning in neurofibromatosis clinical trials.,True,Patient-reported outcome tool
27551454,Tumor suppressor Nf2/merlin drives Schwann cell changes following electromagnetic field exposure through Hippo-dependent mechanisms.,True,Molecular mechanism study
27588404,Characterizing the immune microenvironment of malignant peripheral nerve sheath tumor by PD-L1 expression and presence of CD8+ tumor infiltrating lymphocytes.,True,Immunohistochemical analysis tool
27655679,Comprehensive adipocytic and neurogenic tissue microarray analysis of NY-ESO-1 expression - a promising immunotherapy target in malignant peripheral nerve sheath tumor and liposarcoma.,True,Tissue microarray analysis
27706810,"Antitumor effects of 4-methylumbelliferone, a hyaluronan synthesis inhibitor, on malignant peripheral nerve sheath tumor.",True,Drug screening method
27741517,"Ral A, via activating the mitotic checkpoint, sensitizes cells lacking a functional Nf1 to apoptosis in the absence of protein kinase C.",True,Molecular signaling mechanism
27748759,EGFR-Stat3 signalling in nerve glial cells modifies neurofibroma initiation.,True,Molecular signaling mechanism
27755359,Inhibiting p21-Activated Kinase Induces Cell Death in Vestibular Schwannoma and Meningioma via Mitotic Catastrophe.,True,Drug screening method
27760236,Disease Burden and Symptom Structure of Autism in Neurofibromatosis Type 1: A Study of the International NF1-ASD Consortium Team (INFACT).,True,Clinical assessment tool
27773571,NF1 Is a Direct G Protein Effector Essential for Opioid Signaling to Ras in the Striatum.,True,Molecular signaling mechanism
27791021,Physical interaction between neurofibromin and serotonin 5-HT6 receptor promotes receptor constitutive activity.,True,Protein interaction study
27833160,Photothermal therapy improves the efficacy of a MEK inhibitor in neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.,True,Drug combination method
27913619,The Caenorhabditis elegans NF2/Merlin Molecule NFM-1 Nonautonomously Regulates Neuroblast Migration and Interacts Genetically with the Guidance Cue SLT-1/Slit.,True,Animal model (C. elegans)
27920939,Epigenetic mechanisms drive the progression of neurofibromas to malignant peripheral nerve sheath tumors.,True,Epigenetic mechanism study
27923908,Estrogen activation of microglia underlies the sexually dimorphic differences in Nf1 optic glioma-induced retinal pathology.,True,Animal model (sex differences)
27927008,MicroRNA-296-5p Promotes Invasiveness through Downregulation of Nerve Growth Factor Receptor and Caspase-8.,True,Molecular mechanism study
27956228,Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.,True,CRISPR screening method
27956565,Randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1.,True,Clinical trial with assessment tool
27999334,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,True,Genetic sequencing method
28029918,Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas.,True,Drug efficacy study
28039362,Defining the temporal course of murine neurofibromatosis-1 optic gliomagenesis reveals a therapeutic window to attenuate retinal dysfunction.,True,Animal model (temporal analysis)
28051113,"A comprehensive custom panel design for routine hereditary cancer testing: preserving control, improving diagnostics and revealing a complex variation landscape.",True,Genetic panel design tool
28065690,Medium throughput biochemical compound screening identifies novel agents for pharmacotherapy of neurofibromatosis type 1.,True,Drug screening method
28067315,KANK1 inhibits cell growth by inducing apoptosis through regulating CXXC5 in human malignant peripheral nerve sheath tumors.,True,Molecular mechanism study
28068329,The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas.,True,Molecular mechanism study
28099845,Absence of Neurofibromin Induces an Oncogenic Metabolic Switch via Mitochondrial ERK-Mediated Phosphorylation of the Chaperone TRAP1.,True,Metabolic mechanism study
28126595,Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.,True,Proteome analysis method
28166733,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,True,Machine learning classification tool
28191549,Rationally combining anti-VEGF therapy with radiation in NF2 schwannoma.,True,Drug combination method
28193237,Evaluation of quality of life in adults with neurofibromatosis 1 (NF1) using the Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire.,True,Quality of life assessment tool
28195122,Integrated genomic analyses of de novo pathways underlying atypical meningiomas.,True,Genomic analysis method
28256556,An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system.,True,Inflammatory gene signature tool
28392281,Human stem cell modeling in neurofibromatosis type 1 (NF1).,True,Human stem cell modeling
28398289,A high-throughput molecular data resource for cutaneous neurofibromas.,True,High-throughput molecular data resource
28423318,Oligodendrocyte Nf1 Controls Aberrant Notch Activation and Regulates Myelin Structure and Behavior.,True,Genetic/molecular research tool
28425622,Targeted Disruption of NF1 in Osteocytes Increases FGF23 and Osteoid With Osteomalacia-like Bone Phenotype.,True,Genetic disruption model
28427224,Ponatinib promotes a G1 cell-cycle arrest of merlin/NF2-deficient human schwann cells.,True,Cell line experimental method
28454108,Telomere erosion in NF1 tumorigenesis.,True,Genetic mechanism study
28468780,Combined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses NF2 Loss-Driven Tumorigenesis.,True,Molecular inhibition method
28489286,Sustained activation of ERK1/2 MAPK in Schwann cells causes corneal neurofibroma.,True,Molecular signaling mechanism
28502478,The Cellular Retinoic Acid Binding Protein 2 Promotes Survival of Malignant Peripheral Nerve Sheath Tumor Cells.,True,Molecular survival mechanism
28525381,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,True,Cell origin research model
28529006,Validation of a Next-Generation Sequencing Pipeline for the Molecular Diagnosis of Multiple Inherited Cancer Predisposing Syndromes.,True,Next-generation sequencing pipeline
28542306,Gene signature associated with benign neurofibroma transformation to malignant peripheral nerve sheath tumors.,True,Gene signature identification
28548933,KIR2DL5 mutation and loss underlies sporadic dermal neurofibroma pathogenesis and growth.,True,Genetic mutation analysis
28558025,Doxycycline potentiates antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy in malignant peripheral nerve sheath tumor cells.,True,Drug mechanism study
28566755,Merlin is required for coordinating proliferation of two stem cell lineages in the Drosophila testis.,True,Genetic research model
28589254,Characterisation of malignant peripheral nerve sheath tumours in neurofibromatosis-1 using heterogeneity analysis of (18)F-FDG PET.,True,Tumor characterization method
28595424,Animal models of meningiomas.,True,Animal model development
28608929,High-grade serous carcinomas arise in the mouse oviduct via defects linked to the human disease.,True,Animal disease model
28610844,Overexpression of eIF4F components in meningiomas and suppression of meningioma cell growth by inhibiting translation initiation.,True,Molecular inhibition method
28637487,The NF1 somatic mutational landscape in sporadic human cancers.,True,Somatic mutation landscape
28644838,"Characterization and utilization of an international neurofibromatosis web-based, patient-entered registry: An observational study.",True,Patient registry development
28725547,Spatial working memory in neurofibromatosis 1: Altered neural activity and functional connectivity.,True,Neuroimaging research method
28729415,An Essential Role for the Tumor-Suppressor Merlin in Regulating Fatty Acid Synthesis.,True,Molecular mechanism study
28735371,Identifying Symptoms of Distress in Youth Living with Neurofibromatosis Type 1 (NF1).,True,Clinical assessment tool
28753199,Erratum: Capturing the wide variety of impaired fracture healing phenotypes in Neurofibromatosis Type 1 with eight key factors: a computational study.,True,Computational modeling
28764788,Regulation of human glioma cell apoptosis and invasion by miR-152-3p through targeting DNMT1 and regulating NF2 : MiR-152-3p regulate glioma cell apoptosis and invasion.,True,Molecular mechanism study
28776579,Significance of H3K27me3 loss in the diagnosis of malignant peripheral nerve sheath tumors.,True,Diagnostic marker study
28783719,Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS.,True,Molecular inhibition method
28783725,A Braf kinase-inactive mutant induces lung adenocarcinoma.,True,Genetic mutation model
28789444,p53 performs an essential role in mediating the oncogenic stimulus triggered by loss of expression of neurofibromatosis type 2 during in vitro tumor progression.,True,Molecular mechanism study
28813519,"Expression and inhibition of BRD4, EZH2 and TOP2A in neurofibromas and malignant peripheral nerve sheath tumors.",True,Molecular expression study
28831766,NMR resonance assignments of the EVH1 domain of neurofibromin's recruitment factor Spred1.,True,Molecular structural analysis
2884037,Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene.,True,Genetic linkage study
28846462,Immunohistochemical Markers for Prospective Studies in Neurofibromatosis-1 Porcine Models.,True,Immunohistochemical marker development
28848060,Genetic Severity Score predicts clinical phenotype in NF2.,True,Genetic severity scoring
2889831,A genomic search for linkage of neurofibromatosis to RFLPs.,True,Genetic linkage study
28923059,Osteoglycin promotes meningioma development through downregulation of NF2 and activation of mTOR signaling.,True,Molecular mechanism study
2896631,Linkage analysis of von Recklinghausen neurofibromatosis to DNA markers on chromosome 17.,True,Genetic linkage study
28972170,β1 integrin-dependent Rac/group I PAK signaling mediates YAP activation of Yes-associated protein 1 (YAP1) via NF2/merlin.,True,Molecular signaling mechanism
29032173,The reduced osteogenic potential of Nf1-deficient osteoprogenitors is EGFR-independent.,True,Genetic mechanism study
29131833,MEK inhibitors enhance therapeutic response towards ATRA in NF1 associated malignant peripheral nerve sheath tumors (MPNST) in-vitro.,True,Drug mechanism study
29137242,Immune profiling of NF1-associated tumors reveals histologic subtype distinctions and heterogeneity: implications for immunotherapy.,True,Immune profiling method
29179212,LukS-PV-Regulated MicroRNA-125a-3p Promotes THP-1 Macrophages Differentiation and Apoptosis by Down-Regulating NF1 and Bcl-2.,True,Molecular mechanism study
29179472,"BCRP expression in schwannoma, plexiform neurofibroma and MPNST.",True,Molecular expression study
29185159,"The effect of estradiol, testosterone, and human chorionic gonadotropin on the proliferation of Schwann cells with NF1 (+/-) or NF1 (-/-) genotype derived from human cutaneous neurofibromas.",True,Cell proliferation mechanism
29206885,Does elevated glucose metabolism correlate with higher cell density in Neurofibromatosis type 1 associated peripheral nerve sheath tumors?,True,Metabolic mechanism study
29249622,Differential Expression of NF2 in Neuroepithelial Compartments Is Necessary for Mammalian Eye Development.,True,Genetic developmental model
29290338,Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844-848.,True,Genotype-phenotype correlation
29351992,Involvement of Aryl hydrocarbon receptor in myelination and in human nerve sheath tumorigenesis.,True,Molecular mechanism study
29354122,Neurofibromin 1 Impairs Natural Killer T-Cell-Dependent Antitumor Immunity against a T-Cell Lymphoma.,True,Immunological mechanism study
29402968,Integrating Functional Analysis in the Next-Generation Sequencing Diagnostic Pipeline of RASopathies.,True,Functional analysis method
29408605,Nf2 Mutation in Schwann Cells Delays Functional Neural Recovery Following Injury.,True,Genetic mechanism study
29409008,"Targeted next-generation sequencing for differential diagnosis of neurofibromatosis type 2, schwannomatosis, and meningiomatosis.",True,Targeted sequencing method
29409029,The characteristics of 76 atypical neurofibromas as precursors to neurofibromatosis 1 associated malignant peripheral nerve sheath tumors.,True,Tumor characterization method
29415745,Cutaneous neurofibromas in Neurofibromatosis type I: a quantitative natural history study.,True,Quantitative natural history study
29423604,Autism Spectrum Disorder in an Unselected Cohort of Children with Neurofibromatosis Type 1 (NF1).,True,Clinical assessment tool
29426343,Differences in MWCNT- and SWCNT-induced DNA methylation alterations in association with the nuclear deposition.,True,Molecular mechanism study
29440379,Targeting the cMET pathway augments radiation response without adverse effect on hearing in NF2 schwannoma models.,True,Molecular pathway study
29493886,Increased expression of miR-641 contributes to erlotinib resistance in non-small-cell lung cancer cells by targeting NF1.,True,Molecular mechanism study
29515781,CXCR4: A new player in vestibular schwannoma pathogenesis.,True,Molecular pathway study
29566645,"Oscillatory motor patterning is impaired in neurofibromatosis type 1: a behavioural, EEG and fMRI study.",True,Neuroimaging research method
29570943,"The Relationship Between Heart Rate Variability, Psychological Flexibility, and Pain in Neurofibromatosis Type 1.",True,Clinical assessment tool
29587439,NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma.,True,Molecular mechanism study
29590612,A Conserved Circadian Function for the Neurofibromatosis 1 Gene.,True,Molecular mechanism study
29596064,Contributions of inflammation and tumor microenvironment to neurofibroma tumorigenesis.,True,Inflammation research tool development
29626191,Lipid binding promotes the open conformation and tumor-suppressive activity of neurofibromin 2.,True,Protein conformation research method
29629523,Attention Deficit Hyperactivity Disorder in Neurofibromatosis Type 1: Evaluation with a Continuous Performance Test.,True,Clinical assessment tool (performance test)
29632086,Athymic mice reveal a requirement for T-cell-microglia interactions in establishing a microenvironment supportive of Nf1 low-grade glioma growth.,True,Animal model research
29649040,Improvement in Patient-reported Hearing After Treatment With Bevacizumab in People With Neurofibromatosis Type 2.,True,Clinical assessment tool (patient-reported outcome)
29662612,Exploiting mitochondrial and metabolic homeostasis as a vulnerability in NF1 deficient cells.,True,Metabolic research method
29666462,Tranilast inhibits the expression of genes related to epithelial-mesenchymal transition and angiogenesis in neurofibromin-deficient cells.,True,Gene expression research method
29670214,Restoring functional neurofibromin by protein transduction.,True,Protein transduction method
29692918,Bevacizumab in neurofibromatosis type 2 (NF2) related vestibular schwannomas: a nationally coordinated approach to delivery and prospective evaluation.,True,Clinical evaluation approach
29704429,Insights into optic pathway glioma vision loss from mouse models of neurofibromatosis type 1.,True,Animal model research
29715273,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,True,Cell biology research method
29787563,Graph complexity analysis identifies an ETV5 tumor-specific network in human and murine low-grade glioma.,True,Computational network analysis tool
29847659,Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization.,True,Endothelial cell research method
29897904,Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2.,True,Drug discovery computational approach
29914349,Social skills in children with RASopathies: a comparison of Noonan syndrome and neurofibromatosis type 1.,True,Clinical assessment tool (social skills)
29925695,A porcine model of neurofibromatosis type 1 that mimics the human disease.,True,Animal model development
29941005,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,True,Cell culture and 3D model research
29958847,Radiomic biomarkers informative of cancerous transformation in neurofibromatosis-1 plexiform tumors.,True,Radiomics computational tool
29982664,EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma.,True,Therapeutic target identification
30055648,Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts.,True,Patient-derived xenograft model
30112810,Targeting of AKT/ERK/CTNNB1 by DAW22 as a potential therapeutic compound for malignant peripheral nerve sheath tumor.,True,Drug targeting research method
30143526,Merlin/ERM proteins regulate growth factor-induced macropinocytosis and receptor recycling by organizing the plasma membrane:cytoskeleton interface.,True,Cellular mechanism research method
30166301,Effects of methylphenidate on cognition and behaviour in children with neurofibromatosis type 1: a study protocol for a randomised placebo-controlled crossover trial.,True,Clinical assessment tool (trial protocol)
30179114,Abnormal Morphology of Select Cortical and Subcortical Regions in Neurofibromatosis Type 1.,True,Neuroimaging research method
30181519,Targeting Difficult Protein-Protein Interactions with Plain and General Computational Approaches.,True,Computational protein interaction tool
30192842,Use of machine learning to predict cognitive performance based on brain metabolism in Neurofibromatosis type 1.,True,Machine learning computational tool
30271432,Confocal Microscopy Predicts the Risk of Recurrence and Malignant Transformation of Mucocutaneous Neurofibromas in NF-1: An Observational Study.,True,Microscopy assessment tool
30274821,Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.,True,Drug screening method
30274822,Exhaustive non-synonymous variants functionality prediction enables high resolution characterization of the neurofibromin architecture.,True,Computational genetic analysis tool
30284154,"Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis-1 with Everolimus: A Phase II, Open-Label, Single-Arm Trial.",True,Clinical drug trial
30290804,Genetic diagnosis of neurofibromatosis type 1: targeted next- generation sequencing with Multiple Ligation-Dependent Probe Amplification analysis.,True,Genetic diagnostic tool
30335132,A proteasome-resistant fragment of NIK mediates oncogenic NF-κB signaling in schwannomas.,True,Molecular signaling research method
30381327,Identification of a Specific Translational Machinery via TCTP-EF1A2 Interaction Regulating NF1-associated Tumor Growth by Affinity Purification and Data-independent Mass Spectrometry Acquisition (AP-DIA).,True,Proteomic research method
30470263,Tonic ATP-mediated growth suppression in peripheral nerve glia requires arrestin-PP2 and is evaded in NF1.,True,Cellular signaling research method
30478285,Usp9X Regulates Cell Death in Malignant Peripheral Nerve Sheath Tumors.,True,Molecular biology research method
30542122,STAT3 inhibition reduces macrophage number and tumor growth in neurofibroma.,True,Immunological research method
30571760,Neurofibromin haploinsufficiency results in altered spermatogenesis in a mouse model of neurofibromatosis type 1.,True,Animal model research
30615146,Preclinical assessment of MEK1/2 inhibitors for neurofibromatosis type 2-associated schwannomas reveals differences in efficacy and drug resistance development.,True,Preclinical drug efficacy research
30617350,"A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma.",True,Animal model development
30710873,Reduced higher dimensional temporal dynamism in neurofibromatosis type 1.,True,Neurological function assessment tool
30713041,Reprogramming Captures the Genetic and Tumorigenic Properties of Neurofibromatosis Type 1 Plexiform Neurofibromas.,True,Cell reprogramming research method
30728335,Cxcr3-expressing leukocytes are necessary for neurofibroma formation in mice.,True,Animal model immunology research
30737893,"Substantial pain burden in frequency, intensity, interference and chronicity among children and adults with neurofibromatosis Type 1.",True,Clinical pain assessment tool
30744170,SYK Inhibition Potentiates the Effect of Chemotherapeutic Drugs on Neuroblastoma Cells in Vitro.,True,Drug interaction research method
30796033,Overcoming BET Inhibitor Resistance in Malignant Peripheral Nerve Sheath Tumors.,True,Drug resistance research method
30800298,A qualitative study of the impact of plexiform neurofibromas on need fulfilment in adults with neurofibromatosis type 1.,True,Qualitative research assessment tool
30850948,Neddylation inhibitor MLN4924 suppresses cilia formation by modulating AKT1.,True,Cellular mechanism research method
30984524,Next Generation Sequencing Identified a Novel Multi Exon Deletion of the NF1 Gene in a Chinese Pedigree with Neurofibromatosis Type 1.,True,Genetic sequencing method
31009417,Towards a neurobiological understanding of pain in neurofibromatosis type 1: mechanisms and implications for treatment.,True,Pain mechanism research method
31015291,Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins.,True,"Protein interaction research method/home/runner/work/nf-research-tools-schema/nf-research-tools-schema/tool_coverage/scripts/screen_publication_titles.py:85: DeprecationWarning: The model 'claude-3-5-haiku-20241022' is deprecated and will reach end-of-life on February 19th, 2026."
3102622,A computed image analyzing system for quantitation of melanocyte morphology in café-au-lait macules of neurofibromatosis.,True,Image analysis computational tool
31033921,[18F]fluorothymidine and [18F]fluorodeoxyglucose PET Imaging Demonstrates Uptake and Differentiates Growth in Neurofibromatosis 2 Related Vestibular Schwannoma.,True,PET imaging tool
31053133,Burden of adult neurofibromatosis 1: development and validation of a burden assessment tool.,True,Clinical assessment tool development
31053152,Knockdown of HMGA2 regulates the level of autophagy via interactions between MSI2 and Beclin1 to inhibit NF1-associated malignant peripheral nerve sheath tumour growth.,True,Molecular knockdown method
31063758,YAP/TAZ Inhibition Induces Metabolic and Signaling Rewiring Resulting in Targetable Vulnerabilities in NF2-Deficient Tumor Cells.,True,Cellular signaling inhibition method
31081992,"Speech difficulties and patient health communication mediating effects on worry and health-related quality of life in children, adolescents, and young adults with Neurofibromatosis Type 1.",True,Patient-reported outcome assessment tool
31091306,Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformation.,True,Genetic model development
31111915,Genetic and genomic alterations differentially dictate low-grade glioma growth through cancer stem cell-specific chemokine recruitment of T cells and microglia.,True,Genetic and genomic analysis method
31131338,Recombinant Human Bone Morphogenetic Protein 6 Delivered Within Autologous Blood Coagulum Restores Critical Size Segmental Defects of Ulna in Rabbits.,True,Animal model for bone regeneration
3118026,An exclusion map for Von Recklinghausen neurofibromatosis.,True,Genetic linkage mapping
3118028,Von Recklinghausen neurofibromatosis: a linkage study of candidate and random marker genes.,True,Genetic linkage study method
3118030,Linkage analysis of neurofibromatosis.,True,Genetic linkage analysis
3118031,Genetic linkage studies with neurofibromatosis: the question of heterogeneity.,True,Genetic heterogeneity study method
3118032,DNA linkage analysis in Von Recklinghausen neurofibromatosis.,True,DNA linkage analysis method
3118033,Linkage studies in peripheral neurofibromatosis.,True,Genetic linkage study method
3118034,Linkage analysis of peripheral neurofibromatosis to DNA markers on chromosome 8.,True,Chromosome mapping method
3118035,Further exclusion data for the Von Recklinghausen neurofibromatosis gene: a genetic linkage study of 19 polymorphic markers.,True,Genetic marker analysis
31189476,Evaluation of QoL in neurofibromatosis patients: a systematic review and meta-analysis study.,True,Quality of life assessment tool
31201114,Loss of GTPase activating protein neurofibromin stimulates paracrine cell communication via macropinocytosis.,True,Cellular communication mechanism
31201186,An auditory brainstem implant for treatment of unilateral tinnitus: protocol for an interventional pilot study.,True,Clinical intervention protocol
31234911,Enriched expression of NF1 in inhibitory neurons in both mouse and human brain.,True,Gene expression analysis
31291965,ErbB4 promotes malignant peripheral nerve sheath tumor pathogenesis via Ras-independent mechanisms.,True,Molecular mechanism study
31296571,Phosphorylation of Merlin by Aurora A kinase appears necessary for mitotic progression.,True,Molecular phosphorylation mechanism
31312020,"The NF2 tumor suppressor merlin interacts with Ras and RasGAP, which may modulate Ras signaling.",True,Protein interaction analysis
31427883,Targeting Sporadic and Neurofibromatosis Type 1 (NF1) Related Refractory Malignant Peripheral Nerve Sheath Tumors (MPNST) in a Phase II Study of Everolimus in Combination with Bevacizumab (SARC016).,True,Clinical trial protocol
31511601,The Secretomes of Painful Versus Nonpainful Human Schwannomatosis Tumor Cells Differentially Influence Sensory Neuron Gene Expression and Sensitivity.,True,Molecular secretome analysis
31545171,Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1.,True,Optical dopamine monitoring tool
31558455,Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study.,True,Clinical study protocol
31585900,NF2/Merlin suppresses proliferation and induces apoptosis in colorectal cancer cells.,True,Molecular mechanism study
31594823,The Novel Glutamine Antagonist Prodrug JHU395 Has Antitumor Activity in Malignant Peripheral Nerve Sheath Tumor.,True,Drug discovery research
31626572,"Multicenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannoma.",True,Clinical trial protocol
31650029,STING Restricts oHSV Replication and Spread in Resistant MPNSTs but Is Dispensable for Basal IFN-Stimulated Gene Upregulation.,True,Viral replication mechanism
31652930,The Role of Co-Deleted Genes in Neurofibromatosis Type 1 Microdeletions: An Evolutive Approach.,True,Genetic deletion analysis
31730023,Nonsteroidal sulfamate derivatives as new therapeutic approaches for Neurofibromatosis 2 (NF2).,True,Drug development research
31752929,The impact of RASopathy-associated mutations on CNS development in mice and humans.,True,Genetic mutation impact study
31756343,Activation of PLCγ/AKT/IκBα/p65 signaling increases inflammation in mast cells to promote growth of cutaneous neurofibroma.,True,Cellular signaling mechanism
31836666,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,True,Protein structural analysis
31836719,Engaging a community to enable disease-centric data sharing with the NF Data Portal.,True,Data sharing platform development
31848332,A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2.,True,Vaccine development research
31852972,AR facilitates YAP-TEAD interaction with the AM promoter to enhance mast cell infiltration into cutaneous neurofibroma.,True,Molecular interaction mechanism
31860870,Circular RNA NF1-419 enhances autophagy to ameliorate senile dementia by binding Dynamin-1 and Adaptor protein 2 B1 in AD-like mice.,True,Circular RNA mechanism study
31881853,A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01.,True,Clinical drug trial
31915440,Attention Deficit Predicts Intellectual Functioning in Children with Neurofibromatosis Type 1.,True,Neuropsychological assessment
31936793,Contribution of mTOR and PTEN to Radioresistance in Sporadic and NF2-Associated Vestibular Schwannomas: A Microarray and Pathway Analysis.,True,Molecular pathway analysis
32089640,Targeting Refractory Sarcomas and Malignant Peripheral Nerve Sheath Tumors in a Phase I/II Study of Sirolimus in Combination with Ganetespib (SARC023).,True,Clinical drug trial
32098059,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,True,Integrative molecular analysis
32107864,Expanding the Noonan spectrum/RASopathy NGS panel: Benefits of adding NF1 and SPRED1.,True,Genetic panel development
32108657,Diagnostic sequence for early diagnosis of neurofibromatosis type 1 using NIH criteria.,True,Diagnostic criteria development
32144278,Combination therapy with mTOR kinase inhibitor and dasatinib as a novel therapeutic strategy for vestibular schwannoma.,True,Combination therapy research
32152628,Longitudinal evaluation of peripheral nerve sheath tumors in neurofibromatosis type 1: growth analysis of plexiform neurofibromas and distinct nodular lesions.,True,Tumor growth analysis
32181506,Social skills and autism spectrum disorder symptoms in children with neurofibromatosis type 1: evidence for clinical trial outcomes.,True,Clinical assessment tool
32187457,Selumetinib in Children with Inoperable Plexiform Neurofibromas.,True,Pediatric drug trial
32190165,Auditory Brainstem Implantation for Adults With Neurofibromatosis 2 or Severe Inner Ear Abnormalities: A Health Technology Assessment.,True,Clinical intervention assessment
32193437,Longitudinal phenotype development in a minipig model of neurofibromatosis type 1.,True,Animal model development
32193699,Upregulated immuno-modulator PD-L1 in malignant peripheral nerve sheath tumors provides a potential biomarker and a therapeutic target.,True,Biomarker identification
32194680,ADAM9: A novel player in vestibular schwannoma pathogenesis.,True,Molecular pathogenesis study
32212796,The Value of H3K27me3 Immunohistochemistry in Differentiating Malignant Peripheral Nerve Sheath Tumour with Its Histologic Mimickers.,True,Immunohistochemistry method
32245042,Kinome Profiling of NF1-Related MPNSTs in Response to Kinase Inhibition and Doxorubicin Reveals Therapeutic Vulnerabilities.,True,Molecular screening method
32252313,A Novel Treatment Modality for Malignant Peripheral Nerve Sheath Tumor Using a Dual-Effect Liposome to Combine Photodynamic Therapy and Chemotherapy.,True,Drug delivery method
32252413,Genomics of MPNST (GeM) Consortium: Rationale and Study Design for Multi-Omic Characterization of NF1-Associated and Sporadic MPNSTs.,True,Genomic consortium research design
32272491,The Use of MEK Inhibitors in Neurofibromatosis Type 1-Associated Tumors and Management of Toxicities.,True,Clinical drug management protocol
32281771,Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.,True,Genetic reagents screening
32317644,Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2.,True,Vaccine development
32352002,Human Organ-Specific 3D Cancer Models Produced by the Stromal Self-Assembly Method of Tissue Engineering for the Study of Solid Tumors.,True,3D cancer model development
32353955,New Model Systems and the Development of Targeted Therapies for the Treatment of Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors.,True,Animal model development
32354889,Propranolol Specifically Suppresses the Viability of Tumorous Schwann Cells Derived from Plexiform Neurofibromas In Vitro.,True,Cell viability screening
32408052,Mutation-Directed Therapeutics for Neurofibromatosis Type I.,True,Therapeutic strategy development
32438526,Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.,True,Cell line characterization
32461556,Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids.,True,Organoid CRISPR modification
32461616,"Characterising the loss-of-function impact of 5' untranslated region variants in 15,708 individuals.",True,Genetic variant characterization
32471868,Genetic disruption of the small GTPase RAC1 prevents plexiform neurofibroma formation in mice with neurofibromatosis type 1.,True,Animal model development
32494228,Molecular targets for NF1-associated malignant peripheral nerve sheath tumor.,True,Molecular target identification
32599735,From Genes to -Omics: The Evolving Molecular Landscape of Malignant Peripheral Nerve Sheath Tumor.,True,Molecular landscape analysis
32608378,Advanced pharmacological therapies for neurofibromatosis type 1-related tumors.,True,Pharmacological therapy development
32642733,KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors.,True,Potential therapeutic target identification
32642737,Assessing interobserver variability and accuracy in the histological diagnosis and classification of cutaneous neurofibromass.,True,Histological diagnostic tool development
32642739,Clinical trial design in neurofibromatosis type 1 as a model for other tumor predisposition syndromes.,True,Clinical trial design methodology
32642740,Quality of life in patients with neurofibromatosis type 1 and 2 in Canada.,True,Quality of life assessment tool
32699356,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.,True,Animal model development
32733557,"Gene Expression, Network Analysis, and Drug Discovery of Neurofibromatosis Type 2-Associated Vestibular Schwannomas Based on Bioinformatics Analysis.",True,Bioinformatics analysis tool
32781282,Nf1 heterozygous mice recapitulate the anthropometric and metabolic features of human neurofibromatosis type 1.,True,Animal model characterization
3280697,"Monoclonal antibody (AFH1) immunoreactive on morphologically abnormal basal melanocytes within dysplastic nevi, nevocellular nevus nests, and melanoma.",True,Antibody development
32839340,Brain-wide structural and functional disruption in mice with oligodendrocyte-specific Nf1 deletion is rescued by inhibition of nitric oxide synthase.,True,Animal model development
32858845,Systems Biology Approaches Reveal Potential Phenotype-Modifier Genes in Neurofibromatosis Type 1.,True,Computational systems biology approach
32869517,Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.,True,Genome-wide association study
32948135,Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.,True,In vitro model development
33032988,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,True,Drug screening model
33080011,"Temporal, spatial, and genetic constraints contribute to the patterning and penetrance of murine neurofibromatosis-1 optic glioma.",True,Animal model characterization
33082502,Image segmentation of plexiform neurofibromas from a deep neural network using multiple b-value diffusion data.,True,Image segmentation tool
33085177,The development of the PlexiQoL: A patient-reported outcome measure for adults with neurofibromatosis type 1-associated plexiform neurofibromas.,True,Patient-reported outcome measure development
33160273,Modeling tumors of the peripheral nervous system associated with Neurofibromatosis type 1: Reprogramming plexiform neurofibroma cells.,True,Cell reprogramming method
33197677,Effects of a mind-body program on symptoms of depression and perceived stress among adults with neurofibromatosis type 2 who are deaf: A live-video randomized controlled trial.,True,Clinical assessment tool
33273014,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.,True,Cellular model development
33279959,"Stepwise crosstalk between aberrant Nf1, Tp53 and Rb signalling pathways induces gliomagenesis in zebrafish.",True,Animal model development
33356508,C6 Cell Injection into the Optic Nerve of Long-Evans Rats: A Short-Term Model of Optic Pathway Gliomas.,True,Animal model development
33413690,Human cutaneous neurofibroma matrisome revealed by single-cell RNA sequencing.,True,Single-cell RNA sequencing method
33442015,Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.,True,Clinical trial methodology
33484105,Circulating free DNA in the plasma of individuals with neurofibromatosis type 1.,True,Biomarker detection method
33507258,Assessment of RAS Dependency for BRAF Alterations Using Cancer Genomic Databases.,True,Computational genomic analysis
33507822,NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas.,True,Clinical trial design
33574490,Using antisense oligonucleotides for the physiological modulation of the alternative splicing of NF1 exon 23a during PC12 neuronal differentiation.,True,Antisense oligonucleotide genetic reagent
33622177,Chrysophanol inhibits the osteoglycin/mTOR and activats NF2 signaling pathways to reduce viability and proliferation of malignant meningioma cells.,True,Signaling pathway analysis method
33625502,"Efficacy of a Brief, Peer-Delivered Self-management Intervention for Patients With Rare Chronic Diseases: A Randomized Clinical Trial.",True,Clinical assessment tool
33671872,Risk Factors for Bullying Victimization in Children with Neurofibromatosis Type 1 (NF1).,True,Clinical assessment tool
33673681,Hybrid Minigene Assay: An Efficient Tool to Characterize mRNA Splicing Profiles of NF1 Variants.,True,Genetic splicing characterization tool
33767727,Molecular Diagnosis of Neurofibromatosis by Multigene Panel Testing.,True,Molecular diagnostic genetic panel
33817379,Clinical assessment of the use of topical liquid diclofenac following laser microporation of cutaneous neurofibromas in individuals with neurofibromatosis type 1.,True,Clinical assessment tool
33850471,Increased nuclear translation of YAP might act as a potential therapeutic target for NF1-related plexiform neurofibroma.,True,Potential therapeutic target identification
33903738,Identifying challenges in neurofibromatosis: a modified Delphi procedure.,True,Clinical assessment methodology
33911094,"Exploring associations between constipation, severity of neurofibromatosis type 1 and NF1 mutational spectrum.",True,Clinical assessment tool
33948356,Cordycepin inhibits the proliferation of malignant peripheral nerve sheath tumor cells through the p53/Sp1/tubulin pathway.,True,Molecular pathway analysis
33963463,The psychological impact and experience of breast cancer screening in young women with an increased risk of breast cancer due to neurofibromatosis type 1.,True,Psychological impact assessment tool
33963966,Cognitive and Electrophysiological Correlates of Working Memory Impairments in Neurofibromatosis Type 1.,True,Cognitive assessment tool
33972401,Associative Learning Requires Neurofibromin to Modulate GABAergic Inputs to Drosophila Mushroom Bodies.,True,Genetic model system
34010628,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,True,Stem cell model system
34011935,Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.,True,Potential therapeutic screening
34012067,Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation.,True,Diagnostic criteria development
34020694,"The mediating effects of quality of life, depression, and generalized anxiety on perceived barriers to employment success for people diagnosed with Neurofibromatosis Type 1.",True,Clinical assessment tool
34040258,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,True,Genetic model system
34043012,RNA sequence analysis reveals ITGAL/CD11A as a stromal regulator of murine low-grade glioma growth.,True,RNA sequence analysis tool
34049498,Early differences in auditory processing relate to Autism Spectrum Disorder traits in infants with Neurofibromatosis Type I.,True,Clinical assessment tool
34053190,Transcriptomic signature of painful human neurofibromatosis type 2 schwannomas.,True,Transcriptomic characterization
34065204,RABL6A Regulates Schwann Cell Senescence in an RB1-Dependent Manner.,True,Cellular mechanism study
34075397,PAK1 inhibition reduces tumor size and extends the lifespan of mice in a genetically engineered mouse model of Neurofibromatosis Type 2 (NF2).,True,Animal model system
34079083,WNT5A inhibition alters the malignant peripheral nerve sheath tumor microenvironment and enhances tumor growth.,True,Tumor microenvironment analysis
34123937,Efficacy of Cannabinoids on Spasticity and Chronic Pain in a Patient with Co-occurrence of Multiple Sclerosis and Neurofibromatosis Type 1.,True,Clinical assessment tool
34155781,L-carnitine supplementation for muscle weakness and fatigue in children with neurofibromatosis type 1: A Phase 2a clinical trial.,True,Clinical trial assessment tool
34215596,Acceptance and commitment therapy meets peer-support. Development of a supportive self-care intervention for patients with rare diseases: a multistage development process.,True,Clinical intervention development
34229750,Integrated in silico MS-based phosphoproteomics and network enrichment analysis of RASopathy proteins.,True,Computational bioinformatics tool
34230196,Reliability of Handheld Dynamometry to Measure Focal Muscle Weakness in Neurofibromatosis Types 1 and 2.,True,Clinical assessment tool
34230198,Current Recommendations for Patient-Reported Outcome Measures Assessing Domains of Quality of Life in Neurofibromatosis Clinical Trials.,True,Clinical outcome measure development
34230200,Imaging Evaluation of Plexiform Neurofibromas in Neurofibromatosis Type 1: A Survey-Based Assessment.,True,Imaging evaluation methodology
34230203,Patient Report of Hearing in Neurofibromatosis Type 2: Recommendations for Clinical Trials.,True,Clinical assessment tool
34230204,Measuring the Effect of Cutaneous Neurofibromas on Quality of Life in Neurofibromatosis Type 1.,True,Clinical assessment tool
34230205,Recommendations for Social Skills End Points for Clinical Trials in Neurofibromatosis Type 1.,True,Clinical assessment tool
34230208,Enhancing Neurofibromatosis Clinical Trial Outcome Measures Through Patient Engagement: Lessons From REiNS.,True,Clinical trial methodology
34257279,Neurofibromin regulates metabolic rate via neuronal mechanisms in Drosophila.,True,Genetic model system
34264955,Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK.,True,Drug screening method
34297428,RNA-sequencing highlights differential regulated pathways involved in cell cycle and inflammation in orbitofacial neurofibromas.,True,"RNA sequencing analysis tool/home/runner/work/nf-research-tools-schema/nf-research-tools-schema/tool_coverage/scripts/screen_publication_titles.py:85: DeprecationWarning: The model 'claude-3-5-haiku-20241022' is deprecated and will reach end-of-life on February 19th, 2026."
34352618,Characterization of UMi031-A-2 inducible pluripotent stem cell line with a neurofibromatosis type 2-associated mutation.,True,Induced pluripotent stem cell line
34377779,Impact of MEK Inhibitor Therapy on Neurocognitive Functioning in NF1.,True,Clinical assessment tool
34409538,Depression explains the association between pain intensity and pain interference among adults with neurofibromatosis.,True,Clinical assessment tool
34416167,Anti-PD-1/L1 lead-in before MAPK inhibitor combination maximizes antitumor immunity and efficacy.,True,Immunotherapy screening method
34428430,Treatment during a developmental window prevents NF1-associated optic pathway gliomas by targeting Erk-dependent migrating glial progenitors.,True,Developmental model system
34464388,Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.,True,Genomic sequencing method
34487172,Machine learning approach to differentiation of peripheral schwannomas and neurofibromas: A multi-center study.,True,Machine learning diagnostic tool
34534577,Combined Cyclin-Dependent Kinase Inhibition Overcomes MAPK/Extracellular Signal-Regulated Kinase Kinase Inhibitor Resistance in Plexiform Neurofibroma of Neurofibromatosis Type I.,True,Drug screening method
34570301,Psychological resiliency explains the relationship between emotional distress and quality of life in neurofibromatosis.,True,Psychological assessment tool
34573290,Performance Evaluation of SpliceAI for the Prediction of Splicing of NF1 Variants.,True,Computational prediction tool
34603530,Autophagy is involved in neurofibromatosis type I gene-modulated osteogenic differentiation in human bone mesenchymal stem cells.,True,Cellular mechanism study
34604751,Feasibility of magnetic resonance-guided high-intensity focused ultrasound treatment targeting distinct nodular lesions in neurofibromatosis type 1.,True,Clinical assessment tool
34627329,Executive functions and quality of life in children with neurofibromatosis type 1.,True,Clinical assessment tool
34630515,Assessment of Mosaicism and Detection of Cryptic Alleles in CRISPR/Cas9-Engineered Neurofibromatosis Type 1 and TP53 Mutant Porcine Models Reveals Overlooked Challenges in Precision Modeling of Human Diseases.,True,CRISPR genetic engineering method
34664663,Longitudinal Investigation of Early Motor Development in Neurofibromatosis Type 1.,True,Clinical assessment tool
34692515,SUZ12 Loss Amplifies the Ras/ERK Pathway by Activating Adenylate Cyclase 1 in NF1-Associated Neurofibromas.,True,Molecular pathway analysis
34699786,Inhibition of ERK/MAPK signaling as potential therapy to prevent optic pathway glioma in infants with neurofibromatosis type 1.,True,Potential therapeutic screening
34707296,The structure of neurofibromin isoform 2 reveals different functional states.,True,Protein structural analysis
34728553,RKIP Induction Promotes Tumor Differentiation via SOX2 Degradation in NF2-Deficient Conditions.,True,Molecular mechanism study
34768015,Treatment of cutaneous neurofibromas with carbon dioxide laser: Technique and patient experience.,True,Clinical assessment tool
34779163,[Expert consensus on diagnosis and management of neurofibromatosis type 1 (2021 edition)].,True,Diagnostic criteria development
34782607,Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq.,True,RNA sequencing method
35187488,Immune deconvolution and temporal mapping identifies stromal targets and developmental intervals for abrogating murine low-grade optic glioma formation.,True,Computational immune deconvolution tool
35212372,Characterizing mobile element insertions in 5675 genomes.,True,Genomic mobile element characterization
35332608,Re-evaluation of missense variant classifications in NF2.,True,Genetic variant reclassification tool
35426432,Evaluation of magnetic resonance imaging-based radiomics characteristics for differentiation of benign and malignant peripheral nerve sheath tumors in neurofibromatosis type 1.,True,Radiomics imaging analysis tool
35481324,Evaluating the Evidence: Scientometric Analysis of Highly Cited Neurofibromatosis 1 Publications.,True,Scientometric analysis tool
35511749,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,True,High-throughput screening platform
35546306,"A systematic review and meta-analysis of intellectual, neuropsychological, and psychoeducational functioning in neurofibromatosis type 1.",True,Systematic review and meta-analysis tool
35584348,Tumor and Constitutional Sequencing for Neurofibromatosis Type 1.,True,Tumor and constitutional sequencing
35628517,Molecular Dynamics Simulations Reveal Structural Interconnections within Sec14-PH Bipartite Domain from Human Neurofibromin.,True,Molecular dynamics simulation tool
35677169,Image-Based Differentiation of Benign and Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1.,True,Image-based tumor differentiation tool
35723774,A randomized controlled trial of remote microphone listening devices to treat auditory deficits in children with neurofibromatosis type 1.,True,Randomized controlled trial of assistive device
35735230,Centralizing neurofibromatosis experimental tool knowledge with the NF Research Tools Database.,True,Research tools database
35741605,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas.,True,Drug mining computational tool
35759947,A Systematic Review of Recent and Ongoing Clinical Trials in Patients With the Neurofibromatoses.,True,Clinical trials systematic review
35815410,Schwann cell precursors represent a neural crest-like state with biased multipotency.,True,Cell precursor characterization
35855179,Bibliometric analysis of the top 100 most-cited articles in neurofibromatosis.,True,Bibliometric analysis tool
35855490,Validation of Bromodomain and Extraterminal proteins as therapeutic targets in neurofibromatosis type 2.,True,Therapeutic target validation
35875109,Preclinical Assessment of MEK Inhibitors for Malignant Peripheral Nerve Sheath Tumors Reveals Differences in Efficacy and Adaptive Response.,True,Preclinical drug efficacy assessment
35879407,Intragenic inversions in NF1 gene as pathogenic mechanism in neurofibromatosis type 1.,True,Genetic mechanism identification
35887576,Silver Nanoparticles Selectively Treat Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors in a Neurofibromin-Dependent Manner.,True,Nanoparticle treatment method
35970940,"Cortical inhibition in neurofibromatosis type 1 is modulated by lovastatin, as demonstrated by a randomized, triple-blind, placebo-controlled clinical trial.",True,Clinical trial of intervention
36009591,Identification of Germinal Neurofibromin Hotspots.,True,"Genetic hotspot identification/home/runner/work/nf-research-tools-schema/nf-research-tools-schema/tool_coverage/scripts/screen_publication_titles.py:85: DeprecationWarning: The model 'claude-3-5-haiku-20241022' is deprecated and will reach end-of-life on February 19th, 2026."
36037004,Mechanistic insights from animal models of neurofibromatosis type 1 cognitive impairment.,True,Animal model mechanistic study
36071954,Co-culture of Schwann cells and endothelial cells for synergistically regulating dorsal root ganglion behavior on chitosan-based anisotropic topology for peripheral nerve regeneration.,True,Cell co-culture method
36127120,Cohort profile: life with neurofibromatosis 1 - the Danish NF1 cohort.,True,Cohort study with patient assessment tool
36130486,Single-cell sequencing reveals activation of core transcription factors in PRC2-deficient malignant peripheral nerve sheath tumor.,True,Single-cell sequencing method
36134665,Multiple Nf1 Schwann cell populations reprogram the plexiform neurofibroma tumor microenvironment.,True,Cellular reprogramming model
36139671,Neurofibroma Development in Neurofibromatosis Type 1: Insights from Cellular Origin and Schwann Cell Lineage Development.,True,Cellular development model
36241865,Transplanting neurofibromatosis-1 gene knockout neural stem cells improve functional recovery in rats with spinal cord injury by enhancing the mTORC2 pathway.,True,Neural stem cell transplantation model
36300003,A novel NF2 splicing mutant causes neurofibromatosis type 2 via liquid-liquid phase separation with large tumor suppressor and Hippo pathway.,True,Genetic splicing mutation model
36316421,Non-invasive brain stimulation modulates GABAergic activity in neurofibromatosis 1.,True,Brain stimulation technique
36416236,LPAR1 and aberrantly expressed LPAR3 differentially promote the migration and proliferation of malignant peripheral nerve sheath tumor cells.,True,Molecular migration analysis
36420221,Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype in vitro.,True,Antisense oligonucleotide genetic reagent
36444392,Characterization of health concerns in people with neurofibromatosis type 1.,True,Health concern assessment tool
36459048,Molecular Dissection of Somatic Skeletal Disease in Neurofibromatosis Type 1.,True,Molecular disease characterization
36497280,Knockdown of NCOR2 Inhibits Cell Proliferation via BDNF/TrkB/ERK in NF1-Derived MPNSTs.,True,Gene knockdown method
36604703,The German version of the neurofibromatosis 2 impact on quality of life questionnaire correlates with severity of depression and physician-reported disease severity.,True,Quality of life questionnaire
36619222,Inhibition of YAP Sensitizes the Selumetinib Treatment for Neurofibromatosis Type 1 Related Plexiform Neurofibroma.,True,Drug sensitivity screening
36689660,Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization.,True,Genetic variant analysis
36730269,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,True,Spheroid drug combination screening
36759572,Runx1/3-driven adaptive endoplasmic reticulum stress pathways contribute to neurofibromagenesis.,True,Cellular stress pathway research
36806881,Proteasomal pathway inhibition as a potential therapy for NF2-associated meningioma and schwannoma.,True,Proteasomal pathway inhibition method
36809290,Merlin tumor suppressor function is regulated by PIP2-mediated dimerization.,True,Protein dimerization mechanism
36832459,"Neuropsychiatric Manifestations, Reduced Self-Esteem and Poor Quality of Life in Children and Adolescents with Neurofibromatosis Type 1 (NF1): The Impact of Symptom Visibility and Bullying Behavior.",True,Psychosocial assessment tool
36844630,Genetic variants of cancer‑associated genes analyzed using next‑generation sequencing in small sporadic vestibular schwannomas.,True,Genetic variant sequencing
36849412,Combining SOS1 and MEK Inhibitors in a Murine Model of Plexiform Neurofibroma Results in Tumor Shrinkage.,True,Animal model drug testing
36854987,Modeling nervous system tumors with human stem cells and organoids.,True,Stem cell and organoid modeling
36866403,Atypical neurofibromas reveal distinct epigenetic features with proximity to benign peripheral nerve sheath tumor entities.,True,Epigenetic feature analysis
36868466,A Two-Stage End-to-End Deep Learning Framework for Pathologic Examination in Skin Tumor Diagnosis.,True,Deep learning diagnostic tool
36890585,Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic.,True,Mouse model research
36944680,Cellular mechanisms of heterogeneity in NF2-mutant schwannoma.,True,Cellular mechanism investigation
36959711,Modeling human cancer predisposition syndromes using CRISPR/Cas9 in human cell line models.,True,CRISPR genetic reagent development
36976677,Generation of human iPSC-derived neurofibromaspheres for in vitro and in vivo uses.,True,iPSC-derived neurofibromasphere generation
37140985,Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor.,True,Extracellular matrix characterization
37149083,cNF-Skindex in Adults Living with Neurofibromatosis 1: Severity Strata in France and Validation in United States Adults.,True,Clinical severity assessment tool
37164978,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,True,Multiplatform molecular profiling
37186028,Analysis of 200 unrelated individuals with a constitutional NF1 deep intronic pathogenic variant reveals that variants flanking the alternatively spliced NF1 exon 31 [23a] cause a classical neurofibromatosis type 1 phenotype while altering predominantly NF1 isoform type II.,True,Genetic variant analysis
37217626,New insights into the molecular basis of spinal neurofibromatosis type 1.,True,Molecular basis investigation
37217995,The genetic landscape and possible therapeutics of neurofibromatosis type 2.,True,Genetic landscape analysis
37245145,"RAS Signaling Gone Awry in the Skin: The Complex Role of RAS in Cutaneous Neurofibroma Pathogenesis, Emerging Biological Insights.",True,Molecular signaling research
37246765,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,True,Ex vivo and in vivo tumor model
37276689,Health-related quality of life of children with neurofibromatosis type 1: Analysis of proxy-rated PedsQL and CHQ questionnaires.,True,Quality of life assessment tool
37301319,Distinct Transcriptional Profiles in the Different Phenotypes of Neurofibroma from the Same Subject with Neurofibromatosis 1.,True,Transcriptional profile analysis
37318402,Cutaneous Neurofibroma Heterogeneity: Factors that Influence Tumor Burden in Neurofibromatosis Type 1.,True,Tumor heterogeneity characterization
37330719,Existing and Developing Preclinical Models for Neurofibromatosis Type 1-Related Cutaneous Neurofibromas.,True,Preclinical model development
37353850,Burden of adult neurofibromatosis 1 questionnaire: translation and psychometric properties of the Persian version.,True,Questionnaire translation/validation
37378983,Effect of Mind-Body Skills Training on Quality of Life for Geographically Diverse Adults With Neurofibromatosis: A Fully Remote Randomized Clinical Trial.,True,Quality of life intervention study
37406085,Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma.,True,Drug combination screening
37435433,Neurofibromatosis-1 Gene Mutational Profiles Differ Between Syndromic Disease and Sporadic Cancers.,True,Mutational profile analysis
37440099,The impact of a virtual mind-body program on resilience factors among international English-speaking adults with neurofibromatoses: secondary analysis of a randomized clinical trial.,True,Resilience intervention study
37446790,Icariin Promotes Osteogenic Differentiation in a Cell Model with NF1 Gene Knockout by Activating the cAMP/PKA/CREB Pathway.,True,Cell model with gene knockout
37520682,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,True,Genetic therapy approach
37527526,Cotargeting Phosphoinositide 3-Kinase and Focal Adhesion Kinase Pathways Inhibits Proliferation of NF2 Schwannoma Cells.,True,Pathway inhibition screening
37608248,Aberrant oscillatory activity in neurofibromatosis type 1: an EEG study of resting state and working memory.,True,EEG analysis method
37616542,"Pro-905, a Novel Purine Antimetabolite, Combines with Glutamine Amidotransferase Inhibition to Suppress Growth of Malignant Peripheral Nerve Sheath Tumor.",True,Drug combination screening
37712888,A common single nucleotide variant in the cytokine receptor-like factor-3 (CRLF3) gene causes neuronal deficits in human and mouse cells.,True,Genetic variant characterization
37770931,"Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas.",True,Single-nuclei RNA-sequencing tool
37772407,Potential endpoints for assessment of bone health in persons with neurofibromatosis type 1.,True,Clinical assessment tool development
37817770,Single-cell RNA sequencing of neurofibromas reveals a tumor microenvironment favorable for neural regeneration and immune suppression in a neurofibromatosis type 1 porcine model.,True,"Single-cell RNA sequencing, animal model"
37848948,Perinatal folate levels do not influence tumor latency or multiplicity in a model of NF1 associated plexiform-like neurofibromas.,True,Animal model research
37886501,Simultaneous Inhibition of PI3K and PAK in Preclinical Models of Neurofibromatosis Type 2-related Schwannomatosis.,True,Preclinical model development
37949359,Characterization of Immune Cell Populations of Cutaneous Neurofibromas in Neurofibromatosis 1.,True,Immune cell characterization
37962219,Perspectives of adults with neurofibromatosis regarding the design of psychosocial trials: Results from an anonymous online survey.,True,Patient survey design tool
37990867,Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia.,True,Induced pluripotent stem cell model
37996843,Impact of neurofibromatosis type 1 with plexiform neurofibromas on the health-related quality of life and work productivity of adult patients and caregivers in the UK: a cross-sectional survey.,True,"Quality of life assessment tool/home/runner/work/nf-research-tools-schema/nf-research-tools-schema/tool_coverage/scripts/screen_publication_titles.py:85: DeprecationWarning: The model 'claude-3-5-haiku-20241022' is deprecated and will reach end-of-life on February 19th, 2026."
38008284,Droplet Digital PCR for Fast and Accurate Characterization of NF1 Locus Deletions: Confirmation of the Predominant Maternal Origin of Type-1 Deletions.,True,Droplet digital PCR genetic characterization
38009710,"Mindfulness, coping, and optimism as mechanisms of change in the 3RP-NF intervention.",True,Psychological intervention tool
38057084,Quality of life in patients with neurofibromatosis type 1: a nationwide database study in Japan from 2015 to 2019.,True,Quality of life assessment tool
38086379,Econazole selectively induces cell death in NF1-homozygous mutant tumor cells.,True,Drug screening method
38115252,Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools.,True,Bioinformatics tool development
38127282,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,True,Spatial gene expression profiling
38136356,Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,True,Drug response screening
38140900,Recommendations for assessing appearance concerns related to plexiform and cutaneous neurofibromas in neurofibromatosis 1 clinical trials.,True,Clinical trial assessment tool
38170419,Development of the PROMIS pediatric stigma and extension to the PROMIS pediatric stigma: skin item banks.,True,Patient-reported outcome measure development
38173515,Development of a semi-automatic segmentation technique based on mean magnetic resonance imaging intensity thresholding for volumetric quantification of plexiform neurofibromas.,True,MRI segmentation technique
38175707,Unbalancing cAMP and Ras/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas.,True,Therapeutic pathway investigation
38187038,Novel combination of imipridones and histone deacetylase inhibitors demonstrate cytotoxic effect through integrated stress response in pediatric solid tumors.,True,Drug combination screening
38201517,Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers.,True,"Xenograft model, drug screening"
38203448,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,True,Drug mechanism investigation
38216123,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,True,Metabolic pathway characterization
38229454,Estrogen-induced glial IL-1β mediates extrinsic retinal ganglion cell vulnerability in murine Nf1 optic glioma.,True,Murine model development
38258905,Schwann cells modulate nociception in neurofibromatosis 1.,True,Cellular mechanism investigation
38308315,Brain injury drives optic glioma formation through neuron-glia signaling.,True,Disease model development
38318960,The impact of a virtual mind-body program on symptoms of depression and anxiety among international English-speaking adults with neurofibromatosis.,True,Virtual intervention tool
38321701,Patient-reported measures of tinnitus for individuals with neurofibromatosis type 2-related schwannomatosis: Recommendations for clinical trials.,True,Patient-reported outcome measure
38336988,Simultaneous inhibition of PI3K and PAK in preclinical models of neurofibromatosis type 2-related schwannomatosis.,True,Preclinical model development
38339230,Gender-Specific Fine Motor Skill Learning Is Impaired by Myelin-Targeted Neurofibromatosis Type 1 Gene Mutation.,True,Genetic mouse model
38360927,Neurofibromin 1 controls metabolic balance and Notch-dependent quiescence of murine juvenile myogenic progenitors.,True,Cellular mechanism investigation
38366576,Perceived transition readiness among adolescents and young adults with neurofibromatosis type 1 and plexiform neurofibromas: a cross-sectional descriptive study.,True,Patient readiness assessment tool
38372904,Imaging as an early biomarker to predict sensitivity to everolimus for progressive NF2-related vestibular schwannoma.,True,Imaging biomarker development
38387803,Development of a vestibular schwannoma tumor slice model for pharmacological testing.,True,Tumor slice model development
38402381,Impact of neurofibromatosis type 1 on quality of life using the Skindex-29 questionnaire quality of life in NF1.,True,Quality of life assessment tool
38409461,Diverse learners: learning disabilities and quality of life following mind-body and health education interventions for adults with neurofibromatosis.,True,Learning intervention tool
38458648,C5aR plus MEK inhibition durably targets the tumor milieu and reveals tumor cell phagocytosis.,True,Tumor microenvironment investigation
38475852,Pilot study of the effectiveness of a telehealth group for improving peer relationships for adolescents with neurofibromatosis type 1.,True,Telehealth intervention tool
38480916,p53 modulates kinase inhibitor resistance and lineage plasticity in NF1-related MPNSTs.,True,Drug resistance mechanism
38481529,Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.,True,CRISPR genetic model development
38493052,Association of sociodemographic and clinical factors with the quality of life of Brazilian individuals with Neurofibromatosis type 1: a cross-sectional study.,True,Quality of life assessment tool
38499890,"The PlexiQoL, a patient-reported outcome measure on quality of life in neurofibromatosis type 1-associated plexiform neurofibroma: translation, cultural adaptation and validation into the Dutch language for the Netherlands.",True,Patient-reported outcome measure translation
38502231,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy.,True,Immunotherapy mechanism investigation
38521834,The impact of mental health on health-related quality of life in patients with NF2-related Schwannomatosis.,True,Mental health impact assessment tool
38585724,Pharmacogenomic synthetic lethal screens reveal hidden vulnerabilities and new therapeutic approaches for treatment of NF1-associated tumors.,True,Pharmacogenomic screening
38595983,Conditionally replicative adenovirus as a therapy for malignant peripheral nerve sheath tumors.,True,Viral therapy development
38603731,Raman difference spectroscopy and U-Net convolutional neural network for molecular analysis of cutaneous neurofibroma.,True,Molecular analysis technique
38607967,NF1 mutation-driven neuronal hyperexcitability sets a threshold for tumorigenesis and therapeutic targeting of murine optic glioma.,True,Genetic mouse model
38654147,Whole-exome sequencing revealed a likely pathogenic variant in NF1 causing neurofibromatosis type I and Arrhythmogenic Cardiomyopathy.,True,Whole-exome sequencing
38691597,Effect of NFX-179 MEK inhibitor on cutaneous neurofibromas in persons with neurofibromatosis type 1.,True,Drug effect assessment
38712289,Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2.,True,Zebrafish genetic model
38714355,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,True,Drug and radiation mechanism
38721358,Effect of food on selumetinib pharmacokinetics and gastrointestinal tolerability in adolescents with neurofibromatosis type 1-related plexiform neurofibromas.,True,Drug pharmacokinetics study
38722890,NF-κB1 deficiency promotes macrophage-derived adrenal tumors but decreases neurofibromas in HTLV-I LTR-Tax transgenic mice.,True,Genetic mouse model
38811427,Quality of life in individuals with neurofibromatosis type 1 associated cutaneous neurofibromas: validation of the Dutch cNF-Skindex.,True,Quality of life assessment tool validation
38816530,Nf1 mutation disrupts activity-dependent oligodendroglial plasticity and motor learning in mice.,True,Animal model research
38900740,Revisiting the NPcis mouse model: A new tool to model plexiform neurofibroma.,True,Animal model development
38913608,Dietary intervention rescues a bone porosity phenotype in a murine model of Neurofibromatosis Type 1 (NF1).,True,Animal model research
38923593,The impact of cutaneous neurofibromas on quality of life and mental health in neurofibromatosis type 1.,True,Quality of life assessment tool
38931352,PET Imaging of Neurofibromatosis Type 1 with a Fluorine-18 Labeled Tryptophan Radiotracer.,True,PET imaging tool development
38990917,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,True,Clinical assessment tool (OCT)
39016685,Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss.,True,Chemical genetic screening
39061138,A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids.,True,3D tumor spheroid model
39106942,Investigating therapeutic nonsense suppression in a neurofibromatosis mouse model.,True,Therapeutic nonsense suppression mouse model
39149363,Neurofibromin deficiency alters the patterning and prioritization of motor behaviors in a state-dependent manner.,True,Animal behavior model
39196570,Cutaneous Neurofibromas and Quality of Life in Adults With Neurofibromatosis Type 1.,True,Quality of life assessment tool
39198186,Quality of life and neurological symptoms in patients with neurofibromatosis type 2: a national database study in Japan.,True,Quality of life assessment tool
39201967,"Quality of Life in Children with Neurofibromatosis Type 1: Agreement between Parents and Patients, and the Role of Disease Severity and Visibility.",True,Quality of life assessment tool
39225289,Comparing 3D imaging devices for the measurement of cutaneous neurofibromas in patients with Neurofibromatosis Type 1.,True,3D imaging measurement tool
39234078,"Long-term distress throughout one's life: health-related quality of life, economic and caregiver burden of patients with neurofibromatosis type 1 in China.",True,Quality of life assessment tool
39373898,Identification of Pathogenic Missense Mutations of NF1 Using Computational Approaches.,True,Computational mutation identification tool
39409151,Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1.,True,Genome profiling method
39415595,Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b.,True,Animal model development (zebrafish)
39518076,Leveraging Neural Crest-Derived Tumors to Identify NF1 Cancer Stem Cell Signatures.,True,Cancer stem cell signature identification
39521772,Automatic construction of Petri net models for computational simulations of molecular interaction network.,True,Computational modeling tool
39539654,Quality of life of patients with neurofibromatosis 1-Physical disability does not necessarily result in poor mental health.,True,Quality of life assessment tool
39601046,Role of long non-coding RNAs in neurofibromatosis and Schwannomatosis: pathogenesis and therapeutic potential.,True,Potential genetic reagent research
39620202,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,True,Multiomics computational tool
39669605,Next-generation variant exon screening: Moving forward in routine genetic disease investigations.,True,Genetic screening method
39731295,"Therapeutic effect of novel drug candidate, PRG-N-01, on NF2 syndrome-related tumor.",True,Drug candidate development
39749698,SUCLG1 promotes aerobic respiration and progression in plexiform neurofibroma.,True,Molecular mechanism study with potential research tools
39762421,Selumetinib in adults with NF1 and inoperable plexiform neurofibroma: a phase 2 trial.,True,Clinical trial with therapeutic tool
39786423,"Triple Combination of MEK, BET, and CDK Inhibitors Significantly Reduces Human Malignant Peripheral Nerve Sheath Tumors in Mouse Models.",True,Animal model development
39793045,Hydroxychloroquine prevents resistance and potentiates the antitumor effect of SHP2 inhibition in NF1-associated malignant peripheral nerve sheath tumors.,True,Drug mechanism research
39804140,"Loss of NF1 Accelerates Uveal and Intradermal Melanoma Tumorigenesis, and Oncogenic GNAQ Transforms Schwann Cells.",True,Genetic mechanism study
39824854,Comparison of 1D and 3D volume measurement techniques in NF2-associated vestibular schwannoma monitoring.,True,3D volumetric measurement technique
39840093,Disproportionate adverse event signals of selumetinib in neurofibromatosis type I: insights from FAERS.,True,Pharmacological adverse event analysis
39840811,Allosteric modulation of NF1 GAP: Differential distributions of catalytically competent populations in loss-of-function and gain-of-function mutants.,True,Molecular computational tool
39845289,Evaluating dimensionality reduction of comorbidities for predictive modeling in individuals with neurofibromatosis type 1.,True,Computational predictive modeling
39857943,UBR5 in Tumor Biology: Exploring Mechanisms of Immune Regulation and Possible Therapeutic Implications in MPNST.,True,Molecular mechanism study
39863790,A multicenter study of neurofibromatosis type 1 utilizing deep learning for whole body tumor identification.,True,Deep learning computational tool
39881370,"Spectrophotometric and computational characterization of charge transfer complex of selumetinib with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone and its utilization in developing an innovative green and high throughput microwell assay for analysis of bulk form and pharmaceutical formulation.",True,Spectrophotometric and computational method
39890807,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,True,Proteomics analysis tool
39921490,NF2 is Essential for Human Endoderm Development.,True,Developmental biology genetic tool
39948669,How does a preference-based generic health-related quality of life measure perform in patients with a rare disease? Measurement properties of the EQ-5D-Y proxy version among underage patients with neurofibromatosis type 1.,True,Clinical assessment tool
39952425,Sex-dependent variations of retinal function and architecture in a neurofibromatosis type I mouse model with normal vision.,True,Animal model research
39965929,Neurofibromin Deficiency Alters the Patterning and Prioritization of Motor Behaviors in a State-Dependent Manner.,True,Behavioral research tool
39966622,The development of an artificial intelligence auto-segmentation tool for 3D volumetric analysis of vestibular schwannomas.,True,AI auto-segmentation tool
39980445,A molecular array for 10-second diagnosis of common spinal tumor types with picosecond infrared laser mass spectrometry.,True,Molecular diagnostic tool
39996452,Cas9 Mouse Model of Skull Base Meningioma Driven by Combinational Gene Inactivation in Meningeal Cells.,True,Animal model development
40000831,Cancer-independent somatic mutation of the wild-type NF1 allele in normal tissues in neurofibromatosis type 1.,True,Genetic mutation analysis
40025071,Discoidin domain receptor inhibitor DDR1-IN-1 induces autophagy and necroptotic cell death in malignant peripheral nerve sheath tumor.,True,Drug mechanism research
40025578,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,True,CAR-T cell therapy development
40034205,The evolving landscape of NF gene therapy: Hurdles and opportunities.,True,Gene therapy research
40063513,DLK1 Distinguishes Subsets of NF1-Associated Malignant Peripheral Nerve Sheath Tumors with Divergent Molecular Signatures.,True,Molecular classification tool
40075752,Granulocyte-Macrophage Colony Stimulating Factor Receptor Contributes to Plexiform Neurofibroma Initiation.,True,Molecular mechanism study
40087579,Disrupted visual attention relates to cognitive development in infants with Neurofibromatosis Type 1.,True,Cognitive assessment tool
40127956,Cognition and behavior in neurofibromatosis type 1: report and perspective from the Cognition and Behavior in NF1 (CABIN) Task Force.,True,Cognitive assessment review
40128216,The CoREST complex is a therapeutic vulnerability in malignant peripheral nerve sheath tumors.,True,Molecular mechanism study
40140675,Spatial mapping of immune cell environments in NF2-related schwannomatosis vestibular schwannoma.,True,Spatial mapping tool
40168468,Molecular Evidence Supporting MEK Inhibitor Therapy in NF1 Pseudarthrosis.,True,Molecular mechanism study
40169570,A genotype-first approach identifies high incidence of NF1 pathogenic variants with distinct disease associations.,True,Genetic screening method
40188079,"Interactions among Merlin, Arkadia, and SKOR2 mediate NF2-associated human Schwann cell proliferation.",True,Molecular mechanism study
40191916,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",True,Animal model development
40214469,Galectin-1 Inhibition as a Strategy for Malignant Peripheral Nerve Sheath Tumor Treatment.,True,Drug mechanism research
40217315,A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations.,True,Single-cell atlas development
40225167,Functional Assays Combined with Pre-mRNA-Splicing Analysis Improve Variant Classification and Diagnostics for Individuals with Neurofibromatosis Type 1 and Legius Syndrome.,True,Genetic diagnostic tool
40240141,IRX2 and NPTX1 differential regulation of β-catenin underlies MEK-mediated proliferation in human neuroglial cells.,True,Molecular mechanism study
40279245,Loss of neurofibromin induces inflammatory macrophage phenotypic switch and retinal neovascularization via GLUT1 activation.,True,Molecular mechanism study
40291747,High-content microscopy and machine learning characterize a cell morphology signature of NF1 genotype in Schwann cells.,True,High-content microscopy tool
40299482,Sleep Disorders in Pediatric Patients Affected by Neurofibromatosis Type 1: Reports of a Questionnaire and an Apple Watch Sleep Assessment.,True,Sleep assessment tool
40304934,Development of patient reported outcome measures assessing tumor pain intensity and tumor pain interference for individuals with neurofibromatosis type 1 and plexiform neurofibromas: qualitative findings.,True,Patient-reported outcome measure development
40342626,Clinical characterization of neuropathic pain and small fiber impairment in neurofibromatosis.,True,Clinical assessment tool
40352015,Development of a Machine Learning Algorithm for the Prediction of WHO Grade 1 Meningioma Recurrence.,True,Machine learning algorithm development
40394150,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,True,Mass spectrometry analysis tool
40437318,Quantitative MRI of dorsal root ganglion alterations in neurofibromatosis type 1 patients with or without pain.,True,Quantitative MRI technique
40460210,Development of two different eco-friendly label-free platforms for analysis of selumetinib.,True,Analytical method development
40501799,Inhibition of Cxcr4 chemokine receptor signaling improves habituation learning and increases cAMP-PKA signaling in a zebrafish model of Neurofibromatosis type 1.,True,Animal model research
40507334,Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.,True,Biomarker platform development
40529476,Using Durometers to Quantify Stiffness as an Outcome Measure for Cutaneous Neurofibroma in Neurofibromatosis Type 1.,True,Clinical assessment tool
40540562,TGFβ-dependent signaling drives tumor growth and aberrant extracellular matrix dynamics in NF1-associated plexiform neurofibroma.,True,Molecular mechanism study
40563570,The RXR Agonist MSU-42011 Reduces Tumor Burden in a Murine Preclinical NF1-Deficient Model.,True,Animal model research
40567456,Non-invasive brain stimulation reorganises effective connectivity during a working memory task in individuals with Neurofibromatosis Type 1.,True,Brain stimulation research tool
40585258,Single-cell tumor microenvironment profiling informs a circulating proteome test for the interception of malignant transformation in NF1 nerve sheath tumors.,True,Single-cell proteomics tool development
40587782,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",True,Transcriptomic and proteomic atlas
40590220,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,True,Animal model characterization
40617948,Unraveling novel variants in the NF1 gene and investigating potential therapeutic strategies.,True,Genetic variant investigation
40653509,Rare variants modulating phenotype in NF1 carriers.,True,Genetic variant analysis
40661612,High-Throughput Targeted Drug Screening for NF1-associated High-Grade Gliomas with ATRX Deficiency.,True,High-throughput drug screening
40666364,NF1-specific growth charts for head circumference over the first three years of life.,True,Clinical assessment tool (growth charts)
40684195,Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1.,True,Developmental mechanism study
40707701,Pyrimidine addiction: an Achilles' heel of NF2-altered mesothelioma.,True,Molecular targeting research
40713507,Distinct early development trajectories in Nf1(±) and Tsc2(±) mouse models of autism.,True,Developmental trajectory analysis
40723243,The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas.,True,Drug combination screening
40724874,Preclinical Evaluation of Repurposed Antimalarial Artemisinins for the Treatment of Malignant Peripheral Nerve Sheath Tumors.,True,Preclinical drug evaluation
40737523,Clinician Perspectives of a Magnetic Resonance Imaging-Based 3D Volumetric Analysis Tool for Neurofibromatosis Type 2-Related Schwannomatosis: Qualitative Pilot Study.,True,MRI-based 3D volumetric analysis tool
40756144,Molecular Basis of Fracture Pseudarthrosis Associated with Neurofibromatosis Type 1.,True,Molecular mechanism study
40766628,Metabolic and behavioral effects of neurofibromin result from differential recruitment of MAPK and mTOR signaling.,True,Molecular signaling mechanism
40769067,Serum miRNAs as biomarkers in Neurofibromatosis 1: New promising findings.,True,Biomarker discovery
40802118,Real-world experience with selumetinib in children with neurofibromatosis type 1: a multicentric retrospective study.,True,Clinical drug response study
40842566,Translocator protein deficiency blocks the ferroptosis of malignant peripheral nerve sheath tumors through glutathione peroxidase 4.,True,Molecular mechanism investigation
40842873,Evaluating the effect of voxel size on the accuracy of 3D volumetric analysis measurements of brain tumors.,True,Imaging analysis method
40843672,Epigenetic Mechanisms in Neurofibromatosis Types 1 and 2.,True,Epigenetic mechanism research
40862755,Fibroblasts Attenuate Anti-Tumor Drug Efficacy in Tumor Cells via Paracrine Interactions with Tumor Cells in 3D Plexiform Neurofibroma Cultures.,True,3D culture model
40877908,TRAP1 expression elicits pro-tumoral functions in macrophages associated to malignant peripheral nerve sheath tumor cells.,True,Molecular mechanism study
40887659,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,True,Genetic variant prediction tool
40896930,High resolution nerve ultrasound in neurofibromatosis type 1: a prospective and descriptive study.,True,Imaging diagnostic technique
40977920,Cell-free DNA fragmentomics: a universal framework for early cancer detection and monitoring.,True,Cell-free DNA analysis tool
40992926,"Daytime SHP2 inhibitor dosing, when immune cell numbers are elevated, shrinks neurofibromas.",True,Drug targeting research
41001496,T1w/T2w ratio suggests reduced intracortical myelin content in youth with RASopathies.,True,Neuroimaging analysis
41001593,Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor.,True,Molecular mechanism study
41022755,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,True,Gene therapy vector development
41023593,Selective inhibition of BRAF and CRAF sensitizes NF1-deficient malignant peripheral nerve sheath tumors to MEK inhibitors.,True,Drug sensitivity screening
41036607,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,True,Pharmacogenomic screening
41053414,Natural history of SPP1 signaling in NF1 tumors.,True,Molecular signaling study
41149489,Small Extracellular Vesicles Derived from NF2-Associated Schwannoma Cells Modulate Tumor Progression and Immunity via HSP90.,True,Extracellular vesicle characterization
41168866,Artificial intelligence-based tools for precision diagnosis and treatment of neurofibromatosis type 1 associated peripheral and central glial tumors.,True,AI diagnostic tool development
41211508,Ambient ionization mass spectrometry in brain cancer diagnosis.,True,Mass spectrometry diagnostic tool
41223283,Glial-to-mesenchymal transition of tumor Schwann cells drives the genetic burden in MPNSTs from neurofibromatosis type 1 mouse model.,True,Molecular mechanism study
41293003,Variable Schwann cell merlin inactivation is targetable with TEAD1 inhibition in schwannomas.,True,Molecular targeting research
41294711,Neurofibromatosis Type 1 and the Search for Effective Tumor Therapies Using High-Throughput Drug Screening.,True,High-throughput drug screening
41397954,Pharmacological inhibition of RAS pathway alleviates spine deformity in a mouse model of neurofibromatosis type 1.,True,Animal model mechanism study
41411243,PERADIGM: Phenotype embedding similarity-based rare disease gene mapping.,True,Computational gene mapping tool
41437121,The tumour immune microenvironment is enriched but suppressed in vestibular schwannoma compared to meningioma: therapeutic implications for NF2-related schwannomatosis.,True,Tumor microenvironment analysis
41444363,Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model.,True,Drug delivery animal model
41446112,Genetic activation of ERK2 recapitulates core neurodevelopmental features of Rasopathy syndromes in mice.,True,Animal model mechanism study
41463204,The Pathogenesis of the Neurofibroma-to-Sarcoma Transition in Neurofibromatosis Type I: From Molecular Profiles to Diagnostic Applications.,True,Molecular profiling research
41468561,NF1-Specific Growth Charts for Head Circumference Over the First 3 Years of Life.,True,Clinical assessment tool (growth charts)
41480763,NF2 loss malignantly transforms human pancreatic acinar cells and enhances cell fitness under environmental stress.,True,Molecular mechanism study
41480769,Merlin's disappearing act: NF2 loss conjures pancreatic cancer survival in the hostile tumor microenvironment.,True,Molecular mechanism study
41487565,Context-specific targeting of focal adhesion kinase in brain tumors: lessons from glioblastoma and neurofibromatosis type 2-mutant meningioma.,True,Molecular targeting research
41496278,Simultaneous reprogramming and gene correction to generate six iPSC lines and isogenic controls from individuals with neurofibromatosis type 1.,True,iPSC generation and gene correction
41496346,"Midkine as a therapeutic node in NF1-driven neuro‑oncology: Biology, biomarkers, and translational strategies.",True,Therapeutic mechanism research
41533509,Microenvironmental TGF-β is an early driver of NF1-associated tumor formation.,True,Molecular mechanism study
41545416,Asthma-mediated control of optic glioma growth via T cell-microglia interactions: A mathematical model.,True,Mathematical modeling
41564118,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,True,Cell line development
41570527,Novel insights into the regulation of NF2/SWH signaling in granulosa cells of prehierarchical follicle development in hen ovary.,True,Molecular mechanism study
41580779,HMGB1 affects the progression of neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors through E2F2.,True,Molecular mechanism study
41582719,Inhibition of Cxcr4 chemokine receptor signaling improves habituation learning in a zebrafish model of Neurofibromatosis.,True,Animal model behavioral study
41591566,FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study.,True,Molecular characterization tool
41598414,Dermoscopy-Guided High-Frequency Ultrasound Imaging of Subcentimeter Cutaneous and Subcutaneous Neurofibromas in Patients with Neurofibromatosis Type 1.,True,Imaging diagnostic technique
41602242,Perspectives of Patients and Providers on Chronic Pain Assessment in Neurofibromatosis Type 1 (NF1): A Qualitative Study.,True,Chronic pain assessment tool
41616055,Inhibition of focal adhesion kinase impairs tumor formation and preserves hearing in a murine model of NF2-related schwannomatosis.,True,Animal model mechanism study
41631643,Disrupted Frontoparietal Dynamics in Neurofibromatosis Type 1: Reduced Sensitivity and Atypical Modulation During Working Memory.,True,Neuroimaging analysis
41659661,"Mechanical Stiffening Promotes Growth, Invasion, and Mitogen-Activated Protein Kinase Kinase (MEK) Inhibitor Resistance in 3D Plexiform Neurofibroma Cultures.",True,3D culture model
6093111,Characterization of nerve growth factor receptor in neural crest tumors using monoclonal antibodies.,True,Antibody characterization
6417334,Linkage analysis of neurofibromatosis (von Recklinghausen disease).,True,Genetic linkage analysis tool
6451216,An enzyme activity in normal and ataxia telangiectasia cell lines which is involved in the repair of gamma-irradiation-induced DNA damage.,True,Cell line research tool
7474134,Frequent disruption of the Nf1 gene by a novel murine AIDS virus-related provirus in BXH-2 murine myeloid lymphomas.,True,Genetic animal model
7485407,NF2 gene analysis distinguishes hemangiopericytoma from meningioma.,True,Genetic diagnostic tool
7499408,"Inhibition of Ras/Raf interaction by anti-oncogenic mutants of neurofibromin, the neurofibromatosis type 1 (NF1) gene product, in cell-free systems.",True,Molecular interaction analysis
7505343,"Modulation of the neurofibromatosis type 1 gene product, neurofibromin, during Schwann cell differentiation.",True,Cellular differentiation research tool
7570581,"Evidence for the presence of two amino-terminal isoforms of neurofibromin, a gene product responsible for neurofibromatosis type 1.",True,Genetic isoform characterization
7609078,Retroviral integration at the Evi-2 locus in BXH-2 myeloid leukemia cell lines disrupts Nf1 expression without changes in steady-state Ras-GTP levels.,True,Genetic disruption model
7671302,Loss of neurofibromin results in neurotrophin-independent survival of embryonic sensory and sympathetic neurons.,True,Animal model research
7686513,An exon-trapping system with a newly constructed trapping vector pEXT2; its application to the proximal region of the human chromosome 21 long arm.,True,Genetic reagent development
7706208,An exon 8-spliced out transcript of neurofibromatosis 2 gene is constitutively expressed in various human tissues.,True,Genetic transcript analysis
7717450,Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma.,True,Molecular variant analysis
7903272,An EcoRI RFLP in the 5' region of the human NF1 gene.,True,Genetic polymorphism tool
7911002,Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas.,True,Genetic mutation screening
7947085,"Frequency of allele loss of DCC, p53, RBI, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction.",True,Genetic loss analysis tool
7949098,Genetic analysis is consistent with the hypothesis that NF1 limits myeloid cell growth through p21ras.,True,Genetic interaction analysis
7959746,DNA sequences in the promoter region of the NF1 gene are highly conserved between human and mouse.,True,Genetic sequence conservation tool
7977647,Characterization of naturally occurring cutaneous neurofibromatosis in Holstein cattle. A disorder resembling neurofibromatosis type 1 in humans.,True,Animal model development
8051082,Cloning and characterization of a novel epidermal cell surface antigen (ESA).,True,Cell surface antigen characterization
8089100,An anti-Ras function of neurofibromatosis type 2 gene product (NF2/Merlin).,True,Molecular interaction analysis
8105688,Linkage disequilibrium in the neurofibromatosis 1 (NF1) region: implications for gene mapping.,True,Genetic linkage analysis
8176268,Localization of neurofibromin to keratinocytes and melanocytes in developing rat and human skin.,True,Protein localization research
8176761,Modulation of neurofibromatosis type 1 gene expression during in vitro myoblast differentiation.,True,Gene expression analysis
8226742,The GTPase-activating NF1 fragment of 91 amino acids reverses v-Ha-Ras-induced malignant phenotype.,True,Molecular interaction analysis
8226805,Purification of a novel ras GTPase-activating protein from rat brain.,True,Protein purification
8264632,Neurofibromin can inhibit Ras-dependent growth by a mechanism independent of its GTPase-accelerating function.,True,Molecular interaction analysis
8320697,A genetic study of neurofibromatosis type 1 (NF1) in south-western Ontario. II. A PCR based approach to molecular and prenatal diagnosis using linkage.,True,Genetic diagnostic tool
8328449,An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes.,True,Genetic variation analysis
8332934,Neurofibromatosis type 1 gene product (neurofibromin) associates with microtubules.,True,Protein interaction study
8335107,Differential contribution of M(r) 120 kDa rasGTPase-activating protein and neurofibromatosis type 1 gene product during the transition from growth phase to arrested state in human fibroblasts accompanied by a unique rasGTPase-activating activity.,True,Cellular growth analysis
8341688,Suppression of oncogenic Ras by mutant neurofibromatosis type 1 genes with single amino acid substitutions.,True,Molecular mutation analysis
8417346,"A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity.",True,Genetic splice variant analysis
8455625,Differential regulation of cellular activities by GTPase-activating protein and NF1.,True,Molecular interaction analysis
8544190,Characterisation of germline mutations in the neurofibromatosis type 1 (NF1) gene.,True,Genetic mutation characterization
8582272,Neurofibromin-deficient fibroblasts fail to form perineurium in vitro.,True,Cellular differentiation model
8602361,The neurofibromatosis type I messenger RNA undergoes base-modification RNA editing.,True,RNA editing analysis
8612763,Phosphorylation of neurofibromatosis type 1 gene product (neurofibromin) by cAMP-dependent protein kinase.,True,Protein modification analysis
8621451,A naturally occurring T14A11 tract blocks nucleosome formation over the human neurofibromatosis type 1 (NF1)-Alu element.,True,Genetic sequence analysis
8627811,Repression of the NF1 gene by Tax may expain the development of neurofibromas in human T-lymphotropic virus type 1 transgenic mice.,True,Genetic regulation study
8659521,Genotyping of PCR-based polymorphisms and linkage-disequilibrium analysis at the NF1 locus.,True,Genetic polymorphism tool
8751853,Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities.,True,Genetic mutation correlation
8825042,Molecular genetics of neurofibromatosis type 1 (NF1).,True,Molecular genetics review
8892969,NF1 mRNA isoform expression in PC12 cells: modulation by extrinsic factors.,True,Gene expression analysis
8982875,Differential tissue-specific expression of neurofibromin isoform mRNAs in rat.,True,Tissue-specific gene expression
9001241,Nf1-deficient mouse Schwann cells are angiogenic and invasive and can be induced to hyperproliferate: reversion of some phenotypes by an inhibitor of farnesyl protein transferase.,True,Animal model with molecular analysis
9036924,Post-transcriptional regulation of neurofibromin level in cultured human melanocytes in response to growth factors.,True,Protein regulation study
9078372,Neurocristopathy resembling neurofibromatosis type 1 in an NGF-SV40 transgenic line.,True,Transgenic animal model
9136014,Isolation of mutations in the Drosophila homologues of the human Neurofibromatosis 2 and yeast CDC42 genes using a simple and efficient reverse-genetic method.,True,Genetic mutation isolation method
9171370,The Nf2 tumor suppressor gene product is essential for extraembryonic development immediately prior to gastrulation.,True,Genetic knockout model
9222967,Four frameshift mutations in neurofibromatosis type 1 caused by small insertions.,True,Genetic mutation characterization
9391890,Misleading linkage results in an NF2 presymptomatic test owing to mosaicism.,True,Genetic mosaicism analysis
9399891,Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis.,True,Molecular genetic analysis
9430655,"NHE-RF, a regulatory cofactor for Na(+)-H+ exchange, is a common interactor for merlin and ERM (MERM) proteins.",True,Protein interaction study
9458162,A rapid and sensitive protocol for competitive reverse transcriptase (cRT) PCR analysis of cellular genes.,True,Molecular biology method
9516485,"Regulation of the neurofibromatosis type 2 tumor suppressor protein, merlin, by adhesion and growth arrest stimuli.",True,Protein regulation analysis
9553042,Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors.,True,Animal model development
9560242,A role for Pak protein kinases in Schwann cell transformation.,True,Molecular signaling study
9607929,Nf1 regulates hematopoietic progenitor cell growth and ras signaling in response to multiple cytokines.,True,Genetic regulation analysis
9687500,Structural analysis of the GAP-related domain from neurofibromin and its implications.,True,Structural protein domain analysis (likely genetic/molecular research tool)
9703963,Merlin differs from moesin in binding to F-actin and in its intra- and intermolecular interactions.,True,Protein interaction research method
9707592,Mutation frequency declines during spermatogenesis in young mice but increases in old mice.,True,Mutation frequency analysis (genetic research method)
9878702,Region-specific astrogliosis in brains of mice heterozygous for mutations in the neurofibromatosis type 1 (Nf1) tumor suppressor.,True,Animal model research (transgenic mouse model)
